Home Cart Sign in  
Chemical Structure| 111470-99-6 Chemical Structure| 111470-99-6

Structure of Amlodipine Besylate
CAS No.: 111470-99-6

Chemical Structure| 111470-99-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Amlodipine Besylate is a long-acting calcium channel blocker used to lower blood pressure and prevent chest pain.

Synonyms: Amlodipine benzenesulfonate; Amlodipine(benzenesulfonate)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Turek, Marika ; Gach-Janczak, Katarzyna ; Różycka-Sokołowska, Ewa ; Owsianik, Krzysztof ; Bałczewski, Piotr ;

Abstract: Telmisartan (TEL), an angiotensin II receptor blocker (ARB), has poor bioavailability due to its low solubility. To improve dissolution profile and potential therapeutic efficacy of this drug, six TEL-based coamorphous solid dispersions (SDs) were synthesized using mechanochemical neat grinding with various active pharmaceutical ingredients (APIs): hydrochlorothiazide (HCT), amlodipine (AMLO), amlodipine besylate (AMLO-Bes), and rosuvastatin sodium (ROS-Na). The resulting binary and ternary SDs were characterized using X-ray powder diffraction (XRPD), Fourier-transform infrared spectroscopy (FT-IR), and differential scanning calorimetry (DSC). Stability tests confirmed that most SDs were stable for at least 12 months, except for the TEL/HCT system, which recrystallized after two months. Dissolution studies revealed 4–5 fold improvement in TEL release from co-amorphous SDs, especially in formulations with excipients. Cytotoxic activity was evaluated against cancerous (HepG2, MCF-7, HL-60) and normal (HUVEC and MCF-10A) cell lines. The studies revealed a clear synergistic cytotoxic effect of the TEL and ROS-Na combination, which is even more marked on normal cells.

Keywords: Bioavailability ; Cytotoxicity ; Mechanochemistry ; Solid dispersions ; Telmisartan ; Rosuvastatin ; Hydrochlorothiazide

Purchased from AmBeed:

Alternative Products

Product Details of Amlodipine Besylate

CAS No. :111470-99-6
Formula : C26H31ClN2O8S
M.W : 567.05
SMILES Code : O=C(OC)C1=C(NC(=C(C(=O)OCC)C1C=2C=CC=CC2Cl)COCCN)C.O=S(=O)(O)C=1C=CC=CC1
Synonyms :
Amlodipine benzenesulfonate; Amlodipine(benzenesulfonate)
MDL No. :MFCD00887594

Safety of Amlodipine Besylate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P264-P270-P280-P301+P312+P330-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313-P501

Isoform Comparison

Biological Activity

Target
  • Calcium Channel

    Calcium channel, IC50:1.9 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
Rat liver microsomes 1 μM 0, 1, 3, 5, 15, 30, 60 minutes To investigate the effect of curcumin on the metabolic stability of amlodipine. Results showed that curcumin significantly prolonged the half-life of amlodipine (from 34.23 ± 3.33 min to 44.15 ± 4.12 min) and decreased its intrinsic clearance rate (from 40.49 ± 3.26 μL/min/mg protein to 31.39 ± 2.78 μL/min/mg protein). PMC7301706
HL-1 cells 5 µM 1 hour Observe the distribution and accumulation of AML in live cells PMC8158129
A7r5 cells 5 µM 1 hour Observe the distribution and accumulation of AML in live cells PMC8158129
HEK-293 CaV1.2 cells 300 nM 15 minutes Observe the distribution and accumulation of AML in live cells PMC8158129
Human aortic artery-derived VSMCs 5 μM 24 hours To investigate the effect of Amlodipine on miR-21 promoter activity, results showed that Amlodipine enhanced miR-21 promoter activity PMC6555864
Rat aortic artery-derived VSMCs 5 μM 24 hours To investigate the effect of Amlodipine on miR-21 expression, results showed that Amlodipine induced miR-21 overexpression PMC6555864
MGC803 cells 0, 5, 10, 20 µM 24, 48, 72 hours To evaluate the effect of Amlodipine on cell proliferation, results showed that Amlodipine inhibited GC cell proliferation in a dose-dependent manner. PMC11024009
HGC27 cells 0, 5, 10, 20 µM 24, 48, 72 hours To evaluate the effect of Amlodipine on cell proliferation, results showed that Amlodipine inhibited GC cell proliferation in a dose-dependent manner. PMC11024009
TE-1 4-10 μg/mL 24-72 hours To evaluate the inhibitory effect of amlodipine on the proliferation of esophageal cancer cells, the results showed that amlodipine decreased cell viability in a dose- and time-dependent manner. PMC10835542
SKGT-4 4-10 μg/mL 24-72 hours To evaluate the inhibitory effect of amlodipine on the proliferation of esophageal cancer cells, the results showed that amlodipine decreased cell viability in a dose- and time-dependent manner. PMC10835542
Eca109 4-10 μg/mL 24-72 hours To evaluate the inhibitory effect of amlodipine on the proliferation of esophageal cancer cells, the results showed that amlodipine decreased cell viability in a dose- and time-dependent manner. PMC10835542
KYSE-450 4-10 μg/mL 24-72 hours To evaluate the inhibitory effect of amlodipine on the proliferation of esophageal cancer cells, the results showed that amlodipine decreased cell viability in a dose- and time-dependent manner. PMC10835542
Rat liver microsomes 1 μM 60 minutes To investigate the inhibitory effects of triptolide on the metabolic stability of amlodipine. Results showed that triptolide pretreatment prolonged the metabolic half-life of amlodipine from 22.5±4.26 to 36.8±6.37 minutes. PMC6130517
H9c2 cells 2.75 μM 72 hours To evaluate the toxicity of Amlodipine on H9c2 cells and its anti-T. cruzi activity. Results showed that Amlodipine exhibited anti-T. cruzi activity in the micromolar range with moderate toxicity to host cells. PMC7526806

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c nude mice Esophageal cancer xenograft model Oral gavage 13 mg/kg/day Once daily for 15 days To evaluate the inhibitory effect of amlodipine on esophageal cancer growth in vivo, the results showed that amlodipine significantly inhibited tumor growth with a tumor inhibition rate of 30.95%. PMC10835542
Spontaneously hypertensive rats Spontaneously hypertensive rat model Oral 2 mg/kg/day Once daily for 10 weeks To investigate the effect of Amlodipine on miR-21 expression and vascular smooth muscle cell differentiation, results showed that Amlodipine induced miR-21 overexpression and promoted vascular smooth muscle cell differentiation PMC6555864
ApoE-/- mice Atherosclerosis model Chow supplemented 1.5 mg/kg/day Daily administration for 25 weeks To evaluate the effects of amlodipine on atherosclerotic lesion size and composition. Results showed that amlodipine monotherapy did not significantly reduce lesion size, but a trend toward decrease was observed. Additionally, significantly thicker fibrous caps were found in the amlodipine-treated group. PMC4524379
Female Swiss mice T. cruzi Y strain infection model Oral 10 mg/kg Once daily for 5 consecutive days To evaluate the efficacy of Amlodipine in combination with ravuconazole in T. cruzi-infected mice. Results showed that Amlodipine alone lacked trypanocidal activity but significantly enhanced the antiparasitic effect of ravuconazole when used in combination. PMC7526806
NKG mice Subcutaneous xenograft model Oral 10 mg/kg/day Once daily for 28 days To evaluate the effect of Amlodipine on tumor growth in vivo, results showed that Amlodipine significantly reduced tumor growth and volume in SYT4-OE group mice. PMC11024009
Mice Hypertensive BPH/2J and normotensive BPN/3J mice Drinking water 10 mg/kg/day Daily administration until 12 months of age To investigate the effect of amlodipine on BP, BPv, cognitive function, BBB integrity and neuroinflammation in aged hypertensive mice. Results showed that amlodipine normalized SBP and BPv, attenuated short-term memory impairment, and partly reduced microglial inflammatory phenotype. PMC10242521

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02058446 Essential Hypertension Phase 4 Completed - Taiwan ... More >> Taichung Veterans General Hospital Taichung, Taiwan, 40705 Less <<
NCT00591266 Hypertension Phase 3 Completed - -
NCT00627952 Hypertension Phase 3 Completed - Germany ... More >> Clinical Research Center, Department of Nephrology and Hypertension, University of Erlangen-Nurnberg Erlangen, Bavaria, Germany, 91054 Less <<
NCT00591266 - Completed - -
NCT01107743 - Completed - -
NCT02387619 Hypertension ... More >>Hyperlipidemia Less << Phase 1 Completed - Korea, Republic of ... More >> Yonsei University Health System Seoul, Seodaemun-gu, Korea, Republic of, 120-752 Less <<
NCT01107743 - Completed - -
NCT01922687 Arterial and Arteriolar Disord... More >>ers Less << Phase 4 Unknown December 2014 China, Shanghai ... More >> Shanghai Institute of Hypertension Recruiting Shanghai, Shanghai, China, 200025 Contact: Pingjin Gao    64370045 ext 610903    gaopingjin@yahoo.com.cn    Principal Investigator: Pingjin Gao Less <<
NCT00136851 Hypertension Phase 4 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT01080768 Hypertension ... More >>Ankle Edema Less << Phase 2 Terminated(Publication of data... More >> from a similar study made the current study redundant.) Less << - Netherlands ... More >> Novartis Investigative Site Beek en Donk, Netherlands Novartis Investigative Site Bosch, Netherlands Novartis Investigative Site Den Haag, Netherlands Novartis Investigative Site Hoogwoud, Netherlands Novartis Investigative Site Lichtenvoorde, Netherlands Novartis Investigative Site Lieshout, Netherlands Novartis Investigative Site Poortvliet, Netherlands Novartis Investigative Site Utrecht, Netherlands Novartis Investigative Site Wildervank, Netherlands Less <<
NCT01080768 - Terminated(Publication of data... More >> from a similar study made the current study redundant.) Less << - -
NCT02259816 Healthy Phase 1 Completed - -
NCT02047175 Hypertension ... More >>Hyperlipidemia Less << Phase 1 Completed - Korea, Republic of ... More >> The catholic university of Korea, seoul ST.Mary's hospital Seoul, Gangnam-gu, Korea, Republic of Less <<
NCT01197014 Healthy Phase 1 Completed - Czech Republic ... More >> CEPHA s.r.o. Pilsen, Czech Republic Less <<
NCT00542269 - Terminated(Early termination o... More >>f the study due to slow recruitment.) Less << - -
NCT00542269 Hypertension With Metabolic Sy... More >>ndrome Less << Phase 4 Terminated(Early termination o... More >>f the study due to slow recruitment.) Less << - United Kingdom ... More >> Addenbrookes Hospital Cambridge, United Kingdom Less <<
NCT02969265 Hypertension Phase 3 Withdrawn(Business reasons unr... More >>elated to product safety) Less << July 26, 2018 -
NCT01490255 Coronary Artery Disease Phase 4 Unknown June 2014 Italy ... More >> San Raffaele Pisana Recruiting Rome, Italy, 00100 Contact: Giuseppe Marazzi, MD    +39 335 8381320    giuseppe.marazzi@yahoo.com    University La Sapienza Recruiting Rome, Italy, 00166 Contact: Francesco Pelliccia, MD    +393483392006    f.pelliccia@mclink.it Less <<
NCT02738632 Essential Hypertension Phase 3 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT00797862 Hypertension Phase 3 Completed - Canada ... More >> Investigative Site Toronto, Canada Costa Rica Investigative Site San Jose, Costa Rica France Investigative Site Paris, France Germany Investigative Site Bonn, Germany Greece Investigative Site Athens, Greece Guatemala Investigative Site Guatemala city, Guatemala South Africa Investigative Site Cape Town, South Africa Switzerland Investigative Site Basel, Switzerland United Kingdom Investigative Site London, United Kingdom Venezuela Investigative Site Caracas, Venezuela Less <<
NCT03626259 Hypertension Phase 4 Recruiting June 14, 2019 Mexico ... More >> Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara Recruiting Guadalajara, Jalisco, Mexico, 44340 Contact: Fernando Grover Paez, PhD    3310585200 ext 33642    fgroverp@hotmail.com Less <<
NCT01648231 Hypertension Phase 1 Completed - Australia, New South Wales ... More >> GSK Investigational Site Randwick, New South Wales, Australia, 2031 Less <<
NCT01614366 Hypertension Phase 2 Completed - Taiwan ... More >> E-DA Hospital Kaohsiung, Taiwan, 824 Taichung Veterans General Hospital Taichung, Taiwan, 40705 National Taiwan University Hospital Taipei, Taiwan, 100 Mackay Memorial Hospital Taipei, Taiwan, 104 Cheng Hsin General Hospital Taipei, Taiwan, 112 Taipei Veterans General Hospital Taipei, Taiwan, 112 Tri-Service General Hospital Taipei, Taiwan, 114 Chang Gung Memorial Hospital Taoyuan County, Taiwan, 333 Less <<
NCT00797862 - Completed - -
NCT00413049 - Completed - -
NCT00289406 Hypertension Phase 3 Completed - Korea, Republic of ... More >> SKChemicals Seoul, Korea, Republic of Less <<
NCT03116516 Hypertension ... More >>Hyperlipidemia Less << Phase 1 Recruiting December 2017 Korea, Republic of ... More >> Chonbuk National University Hospital Recruiting Jeonju, Korea, Republic of, 561-712 Contact: Mingul Kim, MD Less <<
NCT01844570 - Unknown December 2015 China ... More >> Peking University First Hospital Beijing, China, 100034 Less <<
NCT02059616 Essential Hypertension Phase 2 Unknown December 2015 Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Bundang, Korea, Republic of Dong-A University Hospital Recruiting Busan, Korea, Republic of Yeungnam University Medical Center Recruiting Daegu, Korea, Republic of Konyang University Hospital Recruiting Daejeon, Korea, Republic of Chonnam National University Hospital Recruiting Gwangju, Korea, Republic of Inje University Ilsan Paik Hospital Recruiting Ilsan, Korea, Republic of Inha University Hospital Recruiting Incheon, Korea, Republic of Hallym University Sacred Heart hospital Recruiting Kyungki-do, Korea, Republic of Inje University Haeundae Baik Hospital Recruiting Pusan, Korea, Republic of Pusan National University Hospital Recruiting Pusan, Korea, Republic of Asan Medical Center Recruiting Seoul, Korea, Republic of Ewha Womans University Mokdong Hospital Recruiting Seoul, Korea, Republic of Korea University Guro Hospital Recruiting Seoul, Korea, Republic of Seoul Medical Center Recruiting Seoul, Korea, Republic of Seoul St. Mary's hospital Recruiting Seoul, Korea, Republic of Severance Hospital Recruiting Seoul, Korea, Republic of Soonchunhyang University Hospital Recruiting Seoul, Korea, Republic of Yonsei University Gangnam Severance Hospital Recruiting Seoul, Korea, Republic of Ajou University Hospital Recruiting Suwon, Korea, Republic of Principal Investigator: Seung-Jea Tahk          Wonju Severance Christian Hospital Recruiting Wonju, Korea, Republic of Less <<
NCT01409408 Hypertension ... More >>Diabetes Mellitus Less << Phase 4 Withdrawn(Due to preliminary r... More >>esults of Altitude Trial.) Less << December 2013 Brazil ... More >> Hospital Universitario Pedro Ernesto Rio de Janeiro, Brazil, 20551030 Less <<
NCT00940667 Hypertension Phase 3 Completed - Korea, Republic of ... More >> 13 sites in Korea Seoul, Busan, etc., Korea, Republic of Less <<
NCT01237873 Essential Hypertension Phase 3 Completed - Japan ... More >> Novartis Investigative Site Yokohama, Kanagawa, Japan, 231-0023 Novartis Investigative Site Koshigaya city, Saitama, Japan, 343-0826 Novartis Investigative Site Edogawa-ku, Tokyo, Japan, 133-0061 Novartis Investigative Site Katsushika-ku, Tokyo, Japan, 124-0024 Novartis Investigative Site Kiyose, Tokyo, Japan, 204-0021 Novartis Investigative Site Kunitachi, Tokyo, Japan, 186-0001 Novartis Investigative Site Minato-ku, Tokyo, Japan, 105-7390 Novartis Investigative Site Minato-ku, Tokyo, Japan, 108-0075 Novartis Investigative Site Ota-ku, Tokyo, Japan, 143-0023 Novartis Investigative Site Shibuya-ku, Tokyo, Japan, 150-0002 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 141-0032 Novartis Investigative Site Tachikawa, Tokyo, Japan, 190-0013 Novartis Investigative Site Toshima-ku, Tokyo, Japan, 171-0021 Less <<
NCT00778921 - Completed - -
NCT03038451 Hypertension Phase 4 Completed - Turkey ... More >> Istanbul University Istanbul Medical Faculty Clinical Pharmacology Department Istanbul, Fatih, Turkey, 34093 Less <<
NCT03226340 Essential Hypertension Phase 4 Recruiting March 31, 2018 Korea, Republic of ... More >> Hallym University Medical Center Recruiting Anyang, Dongan-gu, Korea, Republic of, 14068 Contact: Sang-Ho Jo    82-31-380-3722    sophi5neo@gmail.com    Kyung Hee University Hospital Recruiting Seoul, Dongdaemun-gu, Korea, Republic of, 02447 Contact: Soo-Joong Kim    82-2-958-8180    soojoong@dreamwiz.com    Hallym University Medical Center Recruiting Seoul, Gangdong-gu,, Korea, Republic of, 05355 Contact: Kyoo-Rok Han    82-2-2224-2405    krheart@hallym.or.kr    Samsung Medical Center Recruiting Seoul, Gangnam-Gu, Korea, Republic of, 06351 Contact: Sung-Ji Park    82-2-3410-0887    tyche.park@gmail.com    Korea Univ. Guro Hospital Recruiting Seoul, Guro, Korea, Republic of, 08308 Contact: Eung-ju Kim, MD,PhD    82-8-2626-3022    withnoel@empas.com    Seoul National University Hospital Recruiting Seoul, Jongno-gu, Korea, Republic of, 03080 Contact: Hyun-Jai Cho    82-2-2072-3931    hyunjaicho@snu.ac.kr    Hanyang University Medical Center Recruiting Seoul, Seongdong-gu, Korea, Republic of, 04763 Contact: Jin-Ho Shin    82-2-2290-8308    jhs2003@hanyang.ac.kr    Asan Medical Center Recruiting Seoul, Songpa-gu, Korea, Republic of, 05505 Contact: Jong-Min Song    82-2-3010-3158    jmsong@amc.seoul.kr    Ajou Univ. Medical Center Recruiting Suwon-si, Yeong-tong, Korea, Republic of, 16499 Contact: Joon-han Shin, MD,PhD    82-31-219-5710    shinjh@ajou.ac.kr    Seoul National University Bundang Hospital Recruiting Seongnam, Korea, Republic of, 463707 Contact: Dong-Ju Choi, MD, PhD    82-31-787-7007    djchoi@snubh.org    Contact: Jin Joo Park, MD    82-31-787 ext 7074    jinjooparkmd@gmail.com Less <<
NCT01806311 Hypertension Phase 1 Completed - Korea, Republic of ... More >> Chungnam national university hospital,clinical trial center Daejeon, Chungcheongbul-do, Korea, Republic of, 301-721 Less <<
NCT00413049 Hypertension Phase 3 Completed - China ... More >> China-Japan Friendship Hospital Beijing, China, 100029 People's hospital affiliated Beijing University Beijing, China, 100044 The third Xiangya hospital of central south University Changsha, China, 410003 The first hospital affiliated the third military Medical University Chongqing, China, 400038 The third hospital affiliated the third military Medical University Chongqing, China, 400042 Union hospital affiliated Fujian medical University Fuzhou, China, 350001 The first hospital affiliated Fujian medical University Fuzhou, China, 350005 The second hospital affiliated Jiangxi medical school Nanchang, China, 330006 Institute of Hypertension, Ruijin Hospital Shanghai, China, 200025 Zhongshan hospital affiliated Fudan University Shanghai, China, 200032 The sixth people's hospital of Shanghai Shanghai, China, 200233 The first hospital affiliated school of medical of Xi'an Jiaotong University Xi'an, China, 710061 Less <<
NCT03247140 Hypertension With Dyslipidemia Phase 1 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Jeonju, Korea, Republic of Less <<
NCT00931710 - Completed - -
NCT03707899 Hypertension With Dyslipidemia Phase 1 Recruiting June 2019 Korea, Republic of ... More >> Chonbuk National University Hospital Recruiting Jeonju, Korea, Republic of Contact: Min Gul Kim, M.D., Ph D Less <<
NCT03390465 Drug-Drug Interaction Phase 1 Completed - Korea, Republic of ... More >> Inje University Busan Paik Hospital Busan, Korea, Republic of Less <<
NCT00931710 Stage 2 Systolic Hypertension Phase 4 Completed - United States, New Jersey ... More >> sites in USA East Hanover, New Jersey, United States Less <<
NCT02173912 Healthy Volunteers Phase 1 Unknown August 2014 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Chaeyeong Lee          Principal Investigator: Jae-Wook Ko, MD Less <<
NCT01120327 Coronary Artery Disease Phase 4 Unknown December 2011 Korea, Republic of ... More >> Seoul National University Hospital Not yet recruiting Seoul, Korea, Republic of Contact: Hae-Young Lee, MD, PhD    82-10-4528-6160    hylee612@snu.ac.kr Less <<
NCT01977794 Hypertension Phase 3 Completed - Germany ... More >> Please contact the Merck KGaA Communication Center located in Darmstadt, Germany Less <<
NCT01964079 Hypertension Phase 4 Completed - Korea, Republic of ... More >> Wonju Severance Christian Hospital Wonju, Gangwon-do, Korea, Republic of, 220-701 Less <<
NCT03156842 Essential Hypertension ... More >> Dyslipidemia Less << Phase 3 Recruiting May 1, 2019 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Less <<
NCT00778921 Hypertension Phase 3 Completed - Argentina ... More >> Investigative Site Buenos Aires, Argentina Germany Investigative Site Berlin, Germany Norway Investigative Site Oslo, Norway Poland Investigative Site Warsaw, Poland Slovakia Investigative Site Bratislava, Slovakia Sweden Investigative Site Stockholm, Sweden Turkey Investigative Site Ankara, Turkey Less <<
NCT01822639 Hypertension Phase 1 Completed - Australia, New South Wales ... More >> GSK Investigational Site Randwick, New South Wales, Australia, 2031 Less <<
NCT02172040 Hypertension Phase 3 Completed - United Kingdom ... More >> Celerion Belfast, Antrim, United Kingdom, BT9 6AD The Medicines Evaluation Unit Ltd. Manchester, Greater Manchester, United Kingdom, M23 9QZ Reading Clinical Research Aspect Ledbury, Herefordshire, United Kingdom, HR8 2AA Synexus Merseyside Clinical Research Centre Liverpool, Merseyside, United Kingdom, L22 0LG Oldfield Surgery Bath, North East Somerset, United Kingdom, BA2 3HT Rowden Surgery Chippenham, Wiltshire, United Kingdom, SN15 2SB Synexus Midlands Clinical Research Centre Birmingham, United Kingdom, B15 2SQ Synexus Scotland Clinical Research Centre Glasgow, United Kingdom, G20 0SP Barts Health NHS Trust, William Harvey Heart Centre, Barts & The London, Queen Mary School of Medicine and Dentistry, Queen Mary, University of London London, United Kingdom, EC1M 6BQ Reading Clinical Research Aspect Reading, United Kingdom, RG6 6BZ Less <<
NCT01977794 - Completed - -
NCT00667719 Essential Hypertension Phase 3 Completed - United States, Texas ... More >> Investigative Site Houston, Texas, United States Belgium Investigative Site Belgium, Belgium Egypt Investigative Site Egypt, Egypt Germany Investigative Site Germany, Germany Poland Investigative Site Poland, Poland Slovakia Investigative Site Slovakia, Slovakia Spain Investigative Site Spain, Spain Turkey Investigative Site Turkey, Turkey Less <<
NCT01197001 Healthy Phase 1 Completed - Czech Republic ... More >> CEPHA s.r.o. Pilsen, Czech Republic, CZ-323 00 Less <<
NCT02904291 - Recruiting October 2026 Norway ... More >> St. Olavs University Hospital Recruiting Trondheim, Norway Contact: Magnus Strømmen, MSc Less <<
NCT02172040 - Completed - -
NCT03461081 Hypertension With Hyperlipidem... More >>ia Less << Phase 1 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT01177293 Healthy Volunteers Phase 1 Completed - India ... More >> Pfizer Investigational Site Hydrabad, Andhra Pradesh, India, 500 050 Less <<
NCT02739672 Healthy Phase 1 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Chonbuk, Korea, Republic of, 561-712 Less <<
NCT01177293 - Completed - -
NCT01181011 - Completed - -
NCT01181011 Healthy Phase 1 Completed - China ... More >> 1235.30.86001 Boehringer Ingelheim Investigational Site Shanghai, China Less <<
NCT03032315 Healthy Phase 1 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Chonbuk, Korea, Republic of, 561-712 Less <<
NCT01848873 Essential Hypertension Phase 2 Phase 3 Unknown August 2013 China, Anhui ... More >> The First Affiliated Hospital of Anhui Medical University Not yet recruiting Hefei, Anhui, China, 230022 China, Beijing Anzhen Hospital,Capital Medical University Recruiting Beijing, Beijing, China, 100029 Peking University First Hospital Recruiting Beijing, Beijing, China, 100036 Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 China, Fujian First Affiliated Hospital of Fujian Medical University Not yet recruiting Fuzhou, Fujian, China, 350005 China, Guangdong Guangdong General Hospital Not yet recruiting Guangzhou, Guangdong, China, 510030 China, Heilongjiang First Affiliated Hospital of Harbin Medical University Not yet recruiting Haibin, Heilongjiang, China, 150001 China, Hubei Union Hospital, Tongji Medical College,Huazhong University of Science and Technology Not yet recruiting Wuhan, Hubei, China, 430022 China, Jiangsu The Affiliated Hospital of Xuzhou Medical College Recruiting Xuzhou, Jiangsu, China, 221006 China, Jiangxi The Second Affiliated Hospital Of Nanchang University Not yet recruiting Nanchang, Jiangxi, China, 330006 China, Liaoning First Affiliated Hospital of China Medical University Not yet recruiting Shenyang, Liaoning, China, 110002 China, Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine Not yet recruiting Shanghai, Shanghai, China, 200025 Zhongshan Hospital Fudan University Not yet recruiting Shanghai, Shanghai, China, 200032 China, Shanxi First Affiliated Hospital of the School of Medicine, Xi'an Jiaotong University Not yet recruiting Xi'an, Shanxi, China, 710061 China, Sichuan West China School of Medicine, West China Hospital ,Sichuan University Not yet recruiting Chengdu, Sichuan, China, 610041 China, Zhejiang Second Affiliated Hospital, School of Medicine, Zhejiang University Not yet recruiting Hangzhou, Zhejiang, China, 310009 Less <<
NCT01203696 Ischemic Heart Disease Phase 4 Completed - China ... More >> Ruttonjee Hospital Hong Kong SAR, China Less <<
NCT01956786 Essential Hypertension Phase 2 Phase 3 Unknown February 2014 China, Jiangsu ... More >> The Affiliated Hospital of Xuzhou Medical College Not yet recruiting Xuzhou, Jiangsu, China, 221006 Contact: Wang Zhirong, MD    86-0516-85802111    xzzrw@163.com    Principal Investigator: Wang Zhirong, MD          China, Jiangxi The Second Affiliated Hospital of Nanchang University Recruiting Nanchang, Jiangxi, China, 330006 Contact: Cheng Xiaoshu, MD    86-791-6268844    xiaoshumenfan@126.com    Principal Investigator: Cheng Xiaoshu, MD          China, Shanghai Ruijin Hospital, Shanghai Jiao Tong Univesity Recruiting Shanghai, Shanghai, China, 310000 Contact: Wang Jiguang, MD    86-021-64370045    jiguangw@gmail.com    Principal Investigator: Wang Jiguang, MD Less <<
NCT02368652 Essential Hypertension Phase 3 Unknown June 2016 Korea, Republic of ... More >> Hallym University Sungsim Hospital Recruiting Anyang-si, Korea, Republic of Inje University Busan Baik Hospital Recruiting Busan, Korea, Republic of Inje University Haeundae Baik Hospital Recruiting Busan, Korea, Republic of Yeungnam University Medical Center Recruiting Daegu, Korea, Republic of Chonnam National University Hospital Recruiting Gwangju, Korea, Republic of Inje University Ilsan Baik Hospital Recruiting Ilsan, Korea, Republic of Inha University Hospital Recruiting Incheon, Korea, Republic of Seoul National University Bundang Hospital Recruiting Seongnam-si, Korea, Republic of Asan Medical Center Recruiting Seoul, Korea, Republic of Ewha Womans University Mokdong Hospital Recruiting Seoul, Korea, Republic of Gangbuk Samsung Hospital Recruiting Seoul, Korea, Republic of Korea University Anam Hospital Recruiting Seoul, Korea, Republic of Korea University Guro Hospital Recruiting Seoul, Korea, Republic of Seoul Medical Center Recruiting Seoul, Korea, Republic of Seoul St. Mary's Hospital Catholic University Recruiting Seoul, Korea, Republic of Soonchunhyang University Hospital Recruiting Seoul, Korea, Republic of Yonsei University Severance Hospital Recruiting Seoul, Korea, Republic of Ajou University Hospital Recruiting Suwon, Korea, Republic of Principal Investigator: Seungjae Tahk          Wonju Severance Christian Hospital Recruiting Wonju, Korea, Republic of Less <<
NCT02368665 Essential Hypertension Phase 3 Unknown June 2016 Korea, Republic of ... More >> Hallym University Sungsim Hospital Recruiting Anyang-si, Korea, Republic of Inje University Busan Baik Hospital Recruiting Busan, Korea, Republic of Inje University Haeundae Baik Hospital Recruiting Busan, Korea, Republic of Yeungnam University Medical Center Recruiting Daegu, Korea, Republic of Chonnam National University Hospital Recruiting Gwangju, Korea, Republic of Inje University Ilsan Baik Hospital Recruiting Ilsan, Korea, Republic of Inha University Hospital Recruiting Incheon, Korea, Republic of Seoul National University Bundang Hospital Recruiting Seongnam-si, Korea, Republic of Asan Medical Center Recruiting Seoul, Korea, Republic of Ewha Womans University Mokdong Hospital Recruiting Seoul, Korea, Republic of Gangbuk Samsung Hospital Recruiting Seoul, Korea, Republic of Korea University Anam Hospital Recruiting Seoul, Korea, Republic of Korea University Guro Hospital Recruiting Seoul, Korea, Republic of Seoul Medical Center Recruiting Seoul, Korea, Republic of Seoul St. Mary's Hospital Catholic University Recruiting Seoul, Korea, Republic of Soonchunhyang University Hospital Recruiting Seoul, Korea, Republic of Yonsei University Severance Hospital Recruiting Seoul, Korea, Republic of Ajou University Hospital Recruiting Suwon, Korea, Republic of Principal Investigator: Seungjae Tahk          Wonju Severance Christian Hospital Recruiting Wonju, Korea, Republic of Less <<
NCT02069821 Healthy Phase 1 Completed - Korea, Republic of ... More >> Chungnam national university hospital Daejeon, Jung-gu, Korea, Republic of, 301-721 Less <<
NCT01842230 Essential Hypertension ... More >> Hyperlipidemia Less << Phase 1 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of Less <<
NCT01127217 Hypertension Phase 3 Completed - Korea, Republic of ... More >> 8 Sites Seoul, Korea, Republic of Less <<
NCT00853957 Hypertension Phase 4 Completed - United States, Illinois ... More >> Investigative Site Chicago, Illinois, United States United States, Maryland Investigative Site Baltimore, Maryland, United States Investigative Site Oxon Hill, Maryland, United States United States, Michigan Investigative Site Detroit, Michigan, United States United States, New Jersey Investigative Site Trenton, New Jersey, United States United States, New York Investigative Site Brooklyn, New York, United States Investigative Site Springfield Gardens, New York, United States United States, Pennsylvania Investigative Site Philadelphia, Pennsylvania, United States United States, Wisconsin Investigative Site Milwaukeee, Wisconsin, United States Less <<
NCT03106597 Hypertension Phase 4 Recruiting December 10, 2018 Korea, Republic of ... More >> Yonsei University Severance Hospital Recruiting Seoul, Korea, Republic of, 03722 Contact: Sang Hak Lee, MD, PhD    82-10-5472-6911    shl1106@yuhs.ac    Sub-Investigator: Sang Hak Lee, MD, PhD          Korea University Guro Hospital Recruiting Seoul, Korea, Republic of, 08308 Contact: Seung-hoe Song, MBE    82-2-2626-1635    ssessong@korea.ac.kr    Contact: Da-in Lee    82-2-2626-2279    0124dain@gmail.com    Yonsei University Wonju Hospital Recruiting Wonju, Korea, Republic of, 26426 Contact: Jang Young Kim, PhD          Contact    82-10-5360-0463    kimjy@yonsei.ac.kr    Sub-Investigator: Jang Young Kim, PhD Less <<
NCT01113047 Essential Hypertension Phase 3 Completed - Germany ... More >> Investigative Site Pirna, Germany Less <<
NCT00853957 - Completed - -
NCT01841593 - Completed - -
NCT02586311 Hypertension Phase 3 Completed - Korea, Republic of ... More >> Korea University Guro Hospital Seoul, Korea, Republic of Less <<
NCT01841593 HIV Phase 1 Completed - United Kingdom ... More >> St Stephen's AIDS Trust London, United Kingdom, SW10 9TH Less <<
NCT00841815 Healthy Phase 1 Completed - Canada, Ontario ... More >> Biovail Contract Research Toronto, Ontario, Canada Less <<
NCT00841815 - Completed - -
NCT00942994 Hypertension Phase 4 Completed - United States, Arkansas ... More >> K and S Research Services Little Rock, Arkansas, United States, 72201 United States, Florida Well Pharma Medical Research South Miami, Florida, United States, 33143 United States, Massachusetts Hyde Park Health Associates Mattapan, Massachusetts, United States, 02126 United States, Virginia Manassas Clinical Research Center Manassas, Virginia, United States, 20110 United States, Washington Scriber Kidney Center Seattle, Washington, United States, 98133 Less <<
NCT00841542 Healthy Phase 1 Completed - Canada, Ontario ... More >> Biovail Contract Research Toronto, Ontario, Canada Less <<
NCT01395199 Thalassemia I... More >>ron Overload Less << Phase 3 Completed - Brazil ... More >> Universidade Estadual de Campinas Campinas, SP, Brazil, 13100000 Less <<
NCT00841542 - Completed - -
NCT03231982 Hypertension Phase 4 Recruiting May 31, 2019 Korea, Republic of ... More >> Yonsei University Severance Cardiovascular Hospital Recruiting Seoul, Korea, Republic of Contact: Donghoon Choi, M.D., Ph.D.    82-2-2228-8200    cdhlyj@yuhs.ac Less <<
NCT01926652 Healthy Phase 1 Completed - Korea, Republic of ... More >> Chungnam national university hospital, clinical trial center Daejeon, Chungcheongbul-do, Korea, Republic of, 301-721 Less <<
NCT00942994 - Completed - -
NCT02065492 Thalassemia Phase 2 Phase 3 Completed - Pakistan ... More >> Aga Khan University Hospital Karachi, Sindh, Pakistan, 74800 Less <<
NCT03371797 - Completed - Pakistan ... More >> Medicell Karachi, Sindh, Pakistan, 75290 Less <<
NCT01341392 Type 2 Diabetes Mellitus Phase 1 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT01356043 Healthy Male Volunteers Phase 1 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less <<
NCT01797926 Hypertension Phase 1 Completed - South Africa ... More >> GSK Investigational Site Bloemfontein,, South Africa, 9301 Less <<
NCT02544776 Female Infertility Associated ... More >>With Anovulation Less << Not Applicable Completed - -
NCT01278797 Hypertension Phase 1 Completed - Canada, Ontario ... More >> 1235.41.0001 Boehringer Ingelheim Investigational Site Toronto, Ontario, Canada Less <<
NCT01252563 - Completed - -
NCT03226275 Healthy Phase 1 Completed - China ... More >> Xuanwu Hospital Beijing, China, 100053 Less <<
NCT01278797 - Completed - -
NCT03722381 Hemodialysis|Pharmacokinetics WITHDRAWN 2020-01-30 University of Michigan Dialysi... More >>s, Ann Arbor, Michigan, 48109, United States Less <<
NCT00446524 Hypertension Phase 3 Completed - Japan ... More >> Novartis Investigative Site Fukuoka, Japan Less <<
NCT00870571 Healthy Phase 1 Completed - Canada, Quebec ... More >> MDS Pharma Services Saint-Laurent, Montreal, Quebec, Canada, H4R 2N6 Less <<
NCT02979197 Hypertension Phase 3 Completed - United Kingdom ... More >> Oldfield Surgery Bath, United Kingdom, BA2 3HT Celerion Belfast, United Kingdom, BT9 6AD Hathaway Medical Centre Chippenham, United Kingdom, SN14 8GT Rowden Surgery Chippenham, United Kingdom, SN15 2SB Barts Health NHS Trust, Barts Queen Mary University of London, William Harvey Heart Centre London, United Kingdom, EC1M 6BQ Medicines Evaluation Unit Ltd. Manchester, United Kingdom, M23 9QZ St Chad's Surgery Radstock, United Kingdom, BA3 2UH Bradford Road Medical Centre Trowbridge, United Kingdom, BA1 49AR Adcroft Surgery Trowbridge, United Kingdom, BA14 8QA Less <<
NCT00870142 Healthy Phase 1 Completed - Canada, Quebec ... More >> MDS Pharma Services Saint-Laurent, Montreal, Quebec, Canada, H4R 2N6 Less <<
NCT01506011 Fasting Phase 1 Completed - India ... More >> Vimta Labs Ltd. Hyderabad, A.P, India, 500 051 Less <<
NCT01505998 Fed Phase 1 Completed - India ... More >> Vimta Labs Ltd. Hyderabad, A.P, India, 500 051 Less <<
NCT01835418 Hypertension Not Applicable Unknown - -
NCT02292069 Healthy Phase 1 Completed - India ... More >> Veeda Clinical Research Pvt Ltd Ahmedabad, Gujrat, India, 380 015 Less <<
NCT01845272 Healthy Phase 1 Unknown August 2013 -
NCT02064556 Hypertension Phase 1 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Songpa-gu, Korea, Republic of Less <<
NCT02974439 Bioequivalence Phase 1 Completed - China ... More >> Shanghai Haini Pharmaceutical Co., Ltd. Shanghai, China, 201318 Less <<
NCT01131923 Healthy Phase 1 Completed - United States, North Carolina ... More >> AAI Clinic Chapel Hill, North Carolina, United States, 27514 Less <<
NCT03657550 Hypertension Phase 1 Completed - United States, California ... More >> Collaborative Neuroscience Network, LLC Long Beach, California, United States, 90806 Less <<
NCT01155908 Healthy Phase 1 Completed - -
NCT02707913 Healthy Phase 1 Completed - -
NCT02940548 Hypertension Phase 4 Unknown December 2018 China ... More >> Peking University People's Hospital Recruiting Beijing, China, 100044 Contact: Jing Liu, M.D.    861088325457    heartcenter@163.com    Principal Investigator: Jing Liu, M.D. Less <<
NCT03294070 Arterial Hypertension Phase 4 Not yet recruiting August 2018 -
NCT01155895 Healthy Phase 1 Completed - -
NCT02353806 Chronic Hypertension in Pregna... More >>ncy Less << Phase 4 Unknown August 2016 United States, Texas ... More >> Parkland Health and Hospital System Dallas, Texas, United States, 75235 Less <<
NCT02295046 Healthy Phase 1 Completed - Germany ... More >> 3S-Pharmacological Consultation & Research GmbH D-27243 Harpstedt, Koenigsberger, Germany Less <<
NCT01131936 Healthy Phase 1 Completed - United States, North Carolina ... More >> AAI Clinic Chapel Hill, North Carolina, United States, 27514 Less <<
NCT03047538 Arterial Hypertension ... More >> Dyslipidemias Blood Pressure Lipid Metabolism Disorders Less << Phase 4 Recruiting December 31, 2019 Czechia ... More >> Center for Cardiovascular Prevention, Charles University Medical Faculty and Thomayer Hospital Recruiting Prague, Czechia, 140 59 Contact: Peter Wohlfahrt, MD, PhD    +420739777242    wohlfp@gmail.com Less <<
NCT00327587 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals Corporation E. Hanover, New Jersey, United States, 07936 Less <<
NCT00538486 Hypertension ... More >>Obesity Less << Phase 4 Completed - China ... More >> The third hospital affiliated to the Third Military Medical University Chongqing, China, 400042 Less <<
NCT02608242 Hypertension ... More >>Hyperlipidemia Less << Phase 1 Terminated(sponsor decision) - Korea, Republic of ... More >> Chonbuk National University Hospital Chunju, Korea, Republic of, 561-712 Less <<
NCT01819220 Hypertension Phase 4 Completed - Korea, Republic of ... More >> Yonsei universty medical center Seoul, Korea, Republic of, 120-752 Less <<
NCT02789475 Hypertension ... More >>Hyperlipidemias Less << Phase 1 Unknown July 2016 Korea, Republic of ... More >> Inha university hospital Recruiting Jung-gu, Incheon, Korea, Republic of, 400-711 Contact: Chul woo Kim, Ph.D.       cwkim1805@inha.ac.kr Less <<
NCT00294567 Hypertension ... More >>Coronary Atherosclerosis Less << Phase 4 Completed - Japan ... More >> Department of Cardiology, Juntendo University School of Medicine Tokyo, Japan Less <<
NCT00460915 Hypertension Phase 4 Completed - Korea, Republic of ... More >> Korea University Guro Hospital Seoul, Korea, Republic of, 152-703 Less <<
NCT01246193 Hypertension Phase 1 Completed - Korea, Republic of ... More >> Inje Unuversity Pusan Paik Hospital Pusan, Korea, Republic of Less <<
NCT00220220 Essential Hypertension Phase 3 Completed - Germany ... More >> Hamburg, Germany Magdeburg, Germany Messkirch, Germany Stuhr, Germany Tann, Germany Worpswede, Germany Less <<
NCT03009487 Hypertension ... More >>Hyperlipidemias Less << Phase 3 Recruiting - Korea, Republic of ... More >> Seoul national university bundang hospital Recruiting Seoul, Korea, Republic of Contact: Wan Huh    +82-2-550-8106    whuh408@daewoong.co.kr Less <<
NCT03474562 ASCVD Impaire... More >>d Fasting Glucose Hypertension Less << Phase 4 Not yet recruiting October 2019 Korea, Republic of ... More >> Dankook University Hospital Not yet recruiting Cheonan, Korea, Republic of CHA Bundang Medical Center Not yet recruiting Seongnam, Korea, Republic of Gangnam Severance Hospital Not yet recruiting Seoul, Korea, Republic of Severance Hospital Not yet recruiting Seoul, Korea, Republic of Less <<
NCT00624052 - Completed - -
NCT00624052 Hypertension Phase 3 Completed - -
NCT01356017 Healthy Male Volunteers Phase 1 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less <<
NCT00327145 Hypertension Phase 3 Completed - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00330785 Hypertension ... More >>Dyslipidemia Less << Phase 3 Completed - -
NCT00765674 - Completed - -
NCT00350168 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals Corp E. Hanover, New Jersey, United States, 07936 Less <<
NCT00311155 - Completed - -
NCT03738761 Hypertension Phase 4 Recruiting April 2019 Armenia ... More >> Unimed medical center Not yet recruiting Abovyan, Armenia Center of Preventive Cardiology Not yet recruiting Yerevan, Armenia Croatia Thalassotherapia Opatija, Specijalna bolnica za medicinsku rehabilitaciju, bolesti srca, pluća i reumatizma, Klinika za liječenje, rehabilitaciju i prevenciju bolesti srca i krvnih žila Recruiting Opatija, Croatia KBC Rijeka - Sušak, Klinika za internu medicinu, Zavod za nefrologiju, dijalizu i transplantaciju bubrega Recruiting RIjeka, Croatia KB Dubrava, Klinika za unutarnje bolesti, Zavod za nefrologiju i dijalizu Recruiting Zagreb, Croatia KB Merkur, Klinika za unutarnje bolesti, Zavod za kardiologiju Recruiting Zagreb, Croatia KBC Sestre milosrdnice, Klinika za bolesti srca i krvnih žila, Zavod za bolesti krvnih žila Recruiting Zagreb, Croatia KBC Zagreb, Klinika za bolesti srca i krvnih žila Recruiting Zagreb, Croatia KBC Zagreb, Klinika za unutarnje bolesti, Zavod za nefrologiju, arterijsku hipertenziju, dijalizu i transplantaciju Recruiting Zagreb, Croatia Poliklinika za prevenciju kardiovaskularnih bolesti i rehabilitaciju SRČANA Recruiting Zagreb, Croatia Hungary Biatros Kft. Recruiting Biatorbágy, Hungary AD SANITATEM Bt. Recruiting Pilisvörösvár, Hungary Poland Przychodnia Kardiologiczna w Zespole Przychodni Specjalistycznych DIAB-END-COR Active, not recruiting Krakow, Poland Niepubliczny Zakład Opieki Zdrowotnej Neuromed M.i M. Nastaj Spółka Partnerska Recruiting Lublin, Poland Poradnia Kardiologiczna, Nowodworskie Centrum Medyczne Active, not recruiting Nowy Dwór Mazowiecki, Poland Poradnia Kardiologiczna Samodzielnego Publicznego Zespołu Zakładów Opieki Zdrowotnej im. Marszałka Józefa Piłsudskiego w Płońsku Active, not recruiting Płońsk, Poland Poradnia Kardiologiczna w Niepublicznym Zakładzie Opieki Zdrowotnej Euro-Klinika Sp. z o.o. w Siemianowicach Śląskich Active, not recruiting Siemianowice Śląskie, Poland Poradnia internistyczno-kardiologiczna w Niepublicznym Zakładzie Opieki Zdrowotnej AURUM Active, not recruiting Warsaw, Poland Poradnia Kardiologiczna w Przychodni Rejonowej - Specjalistycznej (III) Samodzielnego Zespołu Publicznych Zakładów Lecznictwa Otwartego Warszawa - Ochota Recruiting Warsaw, Poland Przychodnia ACTIV-MED. Recruiting Warsaw, Poland Russian Federation Federal State Budgetary Scientific Institution "Scientific Research Institute of Complex Problems of Cardiovascular Diseases" Recruiting Kemerovo, Russian Federation Federal State budget organization National medical research center of cardiology of the Ministry of healthcare of the Russian Federation Recruiting Moscow, Russian Federation State Budgetary Institution of Healthcare of Moscow "City Clinical Hospital № 29 named after N.E. Bauman of Department of Healthcare of Moscow city" (SBIH "CCH № 29 Bauman") Not yet recruiting Moscow, Russian Federation Federal State Budgetary Institution "V.A. Almazov National Medical Research Center" of the Ministry of Health of the Russian Federation (V.A. Almazov NMRC) Recruiting Saint Petersburg, Russian Federation Federal State Budgetary Educational Institution Higher Education "Volgograd State Medical University" of the Ministry of Healthcare of the Russian Federation (FSBEI HE VolgSMU MOH Russia) Not yet recruiting Volgograd, Russian Federation Serbia Klinički centar Srbije Recruiting Belgrade, Serbia Klinički centar Niš Recruiting Niš, Serbia Inštitut za kardiovaskularne bolesti Vojvodine Recruiting Sremska Kamenica, Serbia Slovenia Univerzitetna klinika za pljučne bolezni in alergijo Golnik Recruiting Golnik, Slovenia Splošna bolnišnica Jesenice Recruiting Jesenice, Slovenia Zdravstveni Zavod CELJENJE Recruiting Koper, Slovenia Ordinacija interne medicine Verboten Kopriva Renata Recruiting Litija, Slovenia Cardial, d. o. o. Recruiting Ljubljana, Slovenia MC Medicor, d. d. Recruiting Ljubljana, Slovenia Intermed, d. o. o. Recruiting Maribor, Slovenia Srce in ožilje, d. o. o. Recruiting Maribor, Slovenia Less <<
NCT00765674 Hypertension Phase 3 Completed - United States, Colorado ... More >> Investigative Site Denver, Colorado, United States Australia Investigative Site Sydney, Australia Canada Investigative Site Ottawa, Canada Denmark Investigative Site Copenhagen, Denmark Germany Investigative Site Berlin, Germany Israel Investigative Site Jerusalem, Israel Italy Investigative Site Rome, Italy Latvia Investigative Site Riga, Latvia Lithuania Investigative Site Vilnius, Lithuania Romania Investigative Site Bucharest, Romania Sweden Investigative Site Stockholm, Sweden Turkey Investigative Site Ankara, Turkey Less <<
NCT00614380 Hypertension Phase 3 Completed - -
NCT00311155 Essential Hypertension Phase 4 Completed - -
NCT01280266 Raynaud Phenomenon Phase 2 Phase 3 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT01280266 - Completed - -
NCT00890591 Essential Hypertension Phase 4 Completed - -
NCT00353912 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals E. Hanover, New Jersey, United States, 07936 Less <<
NCT00890591 - Completed - -
NCT00392262 Hypertension Phase 3 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Basel, Switzerland Less <<
NCT00136773 Albuminuria Phase 4 Completed - -
NCT00159718 Angina Phase 4 Completed - -
NCT00139555 Hypertension ... More >>Left Ventricular Hypertrophy Less << Phase 4 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00170976 HYPERTENSION Phase 3 Completed - Germany ... More >> Sites in germany Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00626743 Hypertension Phase 1 Completed - Korea, Republic of ... More >> INJE University Pusan Paik Hospital Pusan, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Less <<
NCT02655029 - Completed - Greece ... More >> Ippokratio University Hospital of Athens Athens, Greece Less <<
NCT00171002 Hypertension Phase 3 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00618774 - Completed - -
NCT00553267 Hypertension Phase 3 Completed - -
NCT00614380 - Completed - -
NCT00409851 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Sites in Germany, Germany Less <<
NCT00618774 Hypertension Phase 3 Completed - Japan ... More >> 1235.16.004 Boehringer Ingelheim Investigational Site Chofu, Tokyo, Japan 1235.16.006 Boehringer Ingelheim Investigational Site Nishi-ku, Hiroshima, Hiroshima, Japan 1235.16.005 Boehringer Ingelheim Investigational Site Osaka, Osaka, Japan 1235.16.007 Boehringer Ingelheim Investigational Site Osaka, Osaka, Japan 1235.16.003 Boehringer Ingelheim Investigational Site Shinjuku-ku, Tokyo, Japan 1235.16.001 Boehringer Ingelheim Investigational Site Shinjyuku-ku,Tokyo, Japan 1235.16.002 Boehringer Ingelheim Investigational Site Suita, Osaka, Japan Less <<
NCT00553267 - Completed - -
NCT00170963 Hypertension Phase 3 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT02408172 Sleep Apnea Syndrome ... More >> Hypertension Less << Phase 2 Phase 3 Unknown December 2017 China, Jiangsu ... More >> Portable polysomnography Recruiting Suzhou, Jiangsu, China Contact: Jing Yan Piao, MM    86-451-85555333    411483521@qq.com    Hungary Twenty-four-hour ambulatory BP monitoring Recruiting Budapest, Hungary Contact: Jingyan Piao, MM    86-451-85555333    411483521@qq.com    Contact: Yujiao Pan, MM    86-451-85555671    panyujiao@163.com Less <<
NCT00626743 - Completed - -
NCT00741078 Hypertension Phase 4 Completed - Korea, Republic of ... More >> Gil Medical Center Incheon, Korea, Republic of, 405-760 Less <<
NCT01830517 Hypertension ... More >>Stroke Less << Phase 4 Completed - Korea, Republic of ... More >> Boramae Medical Center Boramae-ro 5-gil 20, Dongjak-gu, Seoul, Korea, Republic of, 156-707 Less <<
NCT02734355 Atrial Fibrillation Phase 4 Completed - -
NCT00847262 Hypertension ... More >>Obesity Diabetes Less << Phase 4 Completed - China ... More >> The third hospital affiliated to the Third Military Medical University Chongqing, China, 400042 Less <<
NCT00151619 Chronic Heart Failure Phase 2 Suspended - France ... More >> Service de Réanimation Médicale - Hôpital Raymond Poincaré Garches, France, 92380 Service de Réadaptation Cardio-Vasculaire - Clinique St Yves Rennes, France, 35044 Less <<
NCT02962258 Healthy Subjects Phase 1 Completed - -
NCT01286558 Hypertension Phase 3 Completed - Japan ... More >> 1235.37.01 Boehringer Ingelheim Investigational Site Chuo-ku,Tokyo, Japan 1235.37.07 Boehringer Ingelheim Investigational Site Hiroshima, Hiroshima, Japan 1235.37.08 Boehringer Ingelheim Investigational Site Itoshima, Fukuoka, Japan 1235.37.02 Boehringer Ingelheim Investigational Site Katsushika-ku, Tokyo, Japan 1235.37.05 Boehringer Ingelheim Investigational Site Osaka, Osaka, Japan 1235.37.03 Boehringer Ingelheim Investigational Site Ota-ku, Tokyo, Japan 1235.37.06 Boehringer Ingelheim Investigational Site Suita, Osaka, Japan 1235.37.04 Boehringer Ingelheim Investigational Site Yokohama, Kanagawa, Japan Less <<
NCT02734355 - Completed - -
NCT03088254 Dyslipidemia With Hypertension Phase 3 Completed - Korea, Republic of ... More >> Chungnam National University Hospital Daejeon, Korea, Republic of Chonnam National University Hospital Gwangju, Korea, Republic of Seoul National University Bundang Hospital Gyeonggi-do, Korea, Republic of Gachon University Gil Medical Center Incheon, Korea, Republic of Inje University Haeundae Paik Hospital Pusan, Korea, Republic of Ewha Womans University Mokdong Hospital Seoul, Korea, Republic of Kangbuk Samsung Hospital Seoul, Korea, Republic of Korea University Anam Hospital Seoul, Korea, Republic of KyungHee University Hospital at Gangdong Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of SoonChunHyang University Hospital, Seoul Seoul, Korea, Republic of The Catholic University of Korea Seoul St. Mary's Hospital Seoul, Korea, Republic of Less <<
NCT01286558 - Completed - -
NCT01625494 Hypertension Phase 3 Completed - Russian Federation ... More >> Sanofi-Aventis Administrative Office Moscow, Russian Federation Less <<
NCT00649519 Healthy Phase 1 Completed - United States, West Virginia ... More >> Kendle International Inc. Morgantown, West Virginia, United States, 26505 Less <<
NCT00649402 Healhty Phase 1 Completed - United States, West Virginia ... More >> Kendle International Inc. Morgantown, West Virginia, United States, 26505 Less <<
NCT02068495 - Completed - -
NCT01613209 Hypertension Phase 3 Completed - Germany ... More >> Praxis Dr. Loddo Rastede, Niedersachsen, Germany, 26180 Praxis Dr. Paschmionka Leipzig, Sachsen, Germany, 04316 Praxis Dr. Reimer Anderbeck, Germany, 38836 Praxis Dr. Heinz Bergisch-Gladbach, Germany, 51429 Praxis Dr. Zemmrich Berlin, Germany, 12043 Praxis Dr. Biedermann Blankenhain, Germany, 99444 St.-Josefs-Hospital Cloppenburg, Germany, 49661 Praxis Dr. Pohl Dresden, Germany, 01129 Praxis Koßler-Wiesweg Essen, Germany, 45138 Praxis Dr. Rövenich Frankfurt, Germany, 65929 Praxis Dr. Strzata Kapellendorf, Germany, 99510 Praxis Dr. Pitule Ludwigshafen, Germany, 67061 Less <<
NCT00304226 Hypertension Phase 4 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT02358824 Hypertension Phase 1 Completed - Korea, Republic of ... More >> Kyungpook National University Hospital Daegu, samdeok-dong, 2-ga 50, samdeok-dong, 2-ga 50 Jung-gu, Korea, Republic of, 700-721 Less <<
NCT00548067 Hypertension Phase 3 Completed - India ... More >> Novartis Investigative Site Ahmedabad, India Novartis investigative site Bangalore, India Novartis Investigative site Hyderabad, India Novartis Investigative site Mangalore, India Novartis investigative site Mehasana, India Less <<
NCT02068495 - Completed - -
NCT02569814 Hypertension ... More >>Hyperlipidemia Less << Phase 1 Completed - Korea, Republic of ... More >> Inje University Busan Paik Hospital Busan, Korea, Republic of Less <<
NCT00425373 Essential Hypertension Phase 2 Phase 3 Completed - Japan ... More >> Novartis Pharmaceuticals Tokyo, Japan, 11111 Less <<
NCT00891267 Metabolic Syndrome ... More >> Hypertension Less << Phase 3 Completed - Germany ... More >> Erlangen, Germany Less <<
NCT00159692 Hypertension Phase 4 Completed - -
NCT00425373 - Completed - -
NCT01134393 Hypertension Phase 3 Completed - -
NCT01134393 - Completed - -
NCT00558064 Hypertension Phase 3 Completed - Japan ... More >> 1235.13.037 Boehringer Ingelheim Investigational Site Azumino, Nagano, Japan 1235.13.023 Boehringer Ingelheim Investigational Site Higashiosaka, Osaka, Japan 1235.13.021 Boehringer Ingelheim Investigational Site Itabashi-ku, Tokyo, Japan 1235.13.014 Boehringer Ingelheim Investigational Site Kashihara, Osaka, Japan 1235.13.038 Boehringer Ingelheim Investigational Site Kitaazumi-gun, Nagano, Japan 1235.13.009 Boehringer Ingelheim Investigational Site Kiyose, Tokyo, Japan 1235.13.041 Boehringer Ingelheim Investigational Site Kobe, Hyogo, Japan 1235.13.035 Boehringer Ingelheim Investigational Site Komoro, Nagano, Japan 1235.13.003 Boehringer Ingelheim Investigational Site Koriyama, Fukushima, Japan 1235.13.004 Boehringer Ingelheim Investigational Site Koriyama, Fukushima, Japan 1235.13.027 Boehringer Ingelheim Investigational Site Koriyama, Fukushima, Japan 1235.13.007 Boehringer Ingelheim Investigational Site Koshigaya, Saitama,, Japan 1235.13.008 Boehringer Ingelheim Investigational Site Koto-ku, Tokyo, Japan 1235.13.005 Boehringer Ingelheim Investigational Site Matsudo, Chiba, Japan 1235.13.026 Boehringer Ingelheim Investigational Site Mito, Ibaraki, Japan 1235.13.013 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan 1235.13.016 Boehringer Ingelheim Investigational Site Okayama, Okayama,, Japan 1235.13.040 Boehringer Ingelheim Investigational Site Osaka, Osaka, Japan 1235.13.025 Boehringer Ingelheim Investigational Site Saitama, Saitama, Japan 1235.13.001 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1235.13.024 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1235.13.028 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1235.13.030 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1235.13.031 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1235.13.033 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1235.13.034 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1235.13.002 Boehringer Ingelheim Investigational Site Sendai, Miyagi, Japan 1235.13.018 Boehringer Ingelheim Investigational Site Sendai, Miyagi, Japan 1235.13.019 Boehringer Ingelheim Investigational Site Sendai, Miyagi, Japan 1235.13.036 Boehringer Ingelheim Investigational Site Shimoina-gun, Nagano, Japan 1235.13.042 Boehringer Ingelheim Investigational Site Shinjuku-ku, Tokyo, Japan 1235.13.010 Boehringer Ingelheim Investigational Site Shinjyuku-ku, Tokyo, Japan 1235.13.011 Boehringer Ingelheim Investigational Site Shinjyuku-ku,Tokyo, Japan 1235.13.022 Boehringer Ingelheim Investigational Site Shizuoka, Shizuoka, Japan 1235.13.015 Boehringer Ingelheim Investigational Site Suita, Osaka,, Japan 1235.13.017 Boehringer Ingelheim Investigational Site Takamatsu, Kagawa, Japan 1235.13.029 Boehringer Ingelheim Investigational Site Takamatsu, Kagawa, Japan 1235.13.032 Boehringer Ingelheim Investigational Site Takamatsu, Kagawa, Japan 1235.13.012 Boehringer Ingelheim Investigational Site Takaoka, Toyama, Japan 1235.13.039 Boehringer Ingelheim Investigational Site Takaoka,Toyama, Japan 1235.13.020 Boehringer Ingelheim Investigational Site Tsuchiura, Ibaraki, Japan Less <<
NCT01200407 - Terminated(The requirement for... More >> Post Marketing Surveillance was lifted by the Philippine FDA) Less << - -
NCT00281580 Hypertension Phase 3 Completed - -
NCT01494727 Healthy Phase 1 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT00281580 - Completed - -
NCT01352689 Hypertension Phase 1 Completed - -
NCT03667677 Hypertension ... More >>Anxiety Less << Phase 4 Not yet recruiting July 1, 2020 China, Beijing ... More >> Beijing Friendship Hospital of Capital Medical University Beijing, Beijing, China Beijing Haidian Section of Peking University Third Hospital Beijing, Beijing, China Xuanwu Hospital of Capital Medical University Beijing, Beijing, China China, Chongqing Yongchuan Hospital of Chongqing Medical University Chongqing, Chongqing, China China, Giangsu Zhongda Hospital of Southeast University Nanjing, Giangsu, China China, Hebei Kailuan General Hospital Tangshan, Hebei, China China, Shanxi the First Affiliated Hospital of Shanxi Medical University Taiyuan, Shanxi, China Less <<
NCT01340131 Hypertension Phase 1 Completed - Korea, Republic of ... More >> Inje University Pusan Paik Hospital Pusan, Korea, Republic of Less <<
NCT01004614 Healthy Phase 1 Completed - Japan ... More >> Pfizer Investigational Site Minato-ku, Tokyo, Japan Less <<
NCT00558064 - Completed - -
NCT01180205 Hypertension Phase 4 Unknown October 2011 Germany ... More >> Universitätsmedizin Mainz Mainz, Rheinland-Pfalz, Germany, 55131 Less <<
NCT01738945 We Searched for the Effects of... More >> Calcium Channel Blocker Amlodipine on the Clinical and Laboratory Parameters of Diabetic Patients With Proteinuria. Less << Phase 4 Completed - Turkey ... More >> Gulhane School of Medicine Ankara, Turkey, 06018 Less <<
NCT00171366 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals E. Hanover, New Jersey, United States, 07936 Less <<
NCT00527514 Hypertension Phase 3 Completed - United States, California ... More >> Buena Park, California, United States Long Beach, California, United States Los Angeles, California, United States Sacramento, California, United States Tustin, California, United States Westlake Village, California, United States United States, Colorado Castle Rock, Colorado, United States United States, Florida Pembroke Pines, Florida, United States United States, Illinois Orland Park, Illinois, United States United States, Massachusetts Natick, Massachusetts, United States United States, New York New York, New York, United States United States, North Carolina Winston-Salem, North Carolina, United States United States, Ohio Cincinnati, Ohio, United States United States, Pennsylvania Beaver, Pennsylvania, United States United States, South Carolina Greer, South Carolina, United States United States, Texas Carrolton, Texas, United States Corpus Christi, Texas, United States United States, Wisconsin Madison, Wisconsin, United States Less <<
NCT01004614 - Completed - -
NCT00426478 Hypertension Phase 4 Completed - Taiwan ... More >> National Taiwan University Taipei, R.o.c, Taiwan, 100 Less <<
NCT00527514 - Completed - -
NCT02194309 Healthy Phase 1 Completed - -
NCT00825188 Obesity Hyper... More >>tension Less << Not Applicable Terminated(funding to complete... More >> was inadequate) Less << - United States, Mississippi ... More >> The University of Mississippi Clinical Research Program Jackson, Mississippi, United States, 39216 Less <<
NCT00687973 Hypertension Phase 4 Completed - France ... More >> 2 & 4 rue Lionel Terray BP 308 Rueil-Malmaison, France, 92506 Less <<
NCT00649389 Hypertension Phase 3 Completed - -
NCT02177409 Hypertension Phase 3 Completed - -
NCT00687973 - Completed - -
NCT00649389 - Completed - -
NCT00124969 Kidney Failure, Chronic Phase 4 Completed - Germany ... More >> Charite Campus Benjamin Franklin Berlin, Germany, 12200 Less <<
NCT00902538 - Completed - -
NCT00902538 Essential Hypertension Phase 3 Completed - -
NCT00699192 Hypertension Phase 3 Completed - Czech Republic ... More >> Novartis Investigative site Brno, Czech Republic Investigative site Czech Republic Chrudim, Czech Republic Investigative sites Czech Repbulic Hodonin, Czech Republic Investigative site Czech Repbulic Jicin, Czech Republic Sites in Czech Republic Nachod, Czech Republic Investigative sites Czech Republic Praha, Czech Republic Finland Investigative site Finland Helsinki, Finland Investigative site Finland Joensuu, Finland Investigative site Finland Kerava, Finland Investigative site Finland Tampere, Finland France Investigative site France Paris, France Germany Investigative site Germany Berlin, Germany Hungary Investigative site Hungary Budapest, Hungary Italy Investigative site Italy Rome, Italy Poland Investigative site Poland Warsaw, Poland Slovakia Investigative site Slovakia Bratislava, Slovakia Spain Investigative site Spain Valencia, Spain Sweden Investigative site Sweden Malmo, Sweden Less <<
NCT00699192 - Completed - -
NCT00938197 Essential Hypertension Phase 1 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT01425242 Hypertension ... More >>Abdominal Aortic Aneurysm Less << Not Applicable Terminated(Insufficient number... More >> of participants) Less << - Netherlands ... More >> VU University Medical Center Amsterdam, Netherlands, 1007 MB Less <<
NCT00171054 - Completed - -
NCT02231788 Hypertension Phase 4 Unknown April 2016 Korea, Republic of ... More >> Korea University Ansan Hospital Not yet recruiting Gyeonggi-do, Ansan-si, Korea, Republic of Contact: Sang Yeop Lim, Professor    +82-31-412-5366    vnlover@daum.net    Jeju National University Hospital Recruiting Jeju, Aran, Korea, Republic of Contact: Seung-Jae Joo, Professor    +82-64-717-1701    sejjoo@jejunu.ac.kr    Principal Investigator: Seung-Jae Joo, Professor          Bundang Cha Hospital Recruiting Seongnam, Bundang-gu, Korea, Republic of Contact: Sang-Uk Lim, Professor    +82-31-780-5852    swlim@cha.ac.kr    Principal Investigator: Sang-Uk Lim, Professor          Seoul University Bundang Hospital Recruiting Seongnam, Bundang-gu, Korea, Republic of Contact: Chang-Hwan Yoon, Professor    +82-31-787-7032    Kunson2@snu.ac.kr    Principal Investigator: Chang-Hwan Yoon, Professor          KyungHee University Medical Center Recruiting Seoul, Dongdaemun-gu, Korea, Republic of Contact: Jin-Bae Kim, Professor    +82-2-958-8176    jinbbai@khu.ac.kr    Principal Investigator: Jin-Bae Kim, Professor          Gangnam Severance Hospital Recruiting Seoul, Gangnam-gu, Korea, Republic of Contact: Hyeok-Mun Kwon, Professor    +82-2-2019-3310    kwonhm@yuhs.ac    Principal Investigator: Hyeok-Mun Kwon, Professor          Kumi cha Hospital Recruiting Gumi, Gyeongsangbuk-do, Korea, Republic of Contact: Hyeon-Sang Lee, Professor    +82-54-450-9551    phd75602002@daum.net    Principal Investigator: Hyeon-Sang Lee, Professor          Seoul University Hospital Recruiting Seoul, Jongro-gu, Korea, Republic of Contact: Hyo-Soo Kim, Professor    +82-10-8393-2424    usahyosoo@gmail.com    Principal Investigator: Hyo-Soo Kim, Professor          National Medical Center Recruiting Seoul, Jung-gu, Korea, Republic of Contact: Seung-Min Choi, Professor    +82-2-2260-7565    choichoism@gmail.com    Principal Investigator: Seun-Min Choi, Professor          Kosin University Gospel Hospital Not yet recruiting Busan, Seo-gu, Korea, Republic of Contact: Hyoung Im Cho, Professor    +82-51-990-6105    kyoungim74@gmail.com    Sejong Hospital Recruiting Bucheon, Wonmi, Korea, Republic of Contact: Yeong-Jin Choi, Professor    +82-32-340-1433    cyjheart@gmail.com    Principal Investigator: Yeong-Jin Choi, Professor          Hallym University Kangnam Sacred Heart Hosipital Recruiting Seoul, Yeongdeungpo-gu, Korea, Republic of Contact: Nam-Ho Lee, Professor    +82-2-829-5395    Namholee2@hotmail.com    Principal Investigator: Nam-Ho Lee, Professor Less <<
NCT00409643 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Sites in Germany Germany, Germany Less <<
NCT00400777 Hypertension Phase 4 Completed - Brazil ... More >> Novartis Rio de Janeiro, Brazil, RJ 20551-030 Less <<
NCT00171054 Hypertension Phase 4 Completed - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT02548286 Hypertension Phase 1 Completed - Korea, Republic of ... More >> Chungnam National University Hospital Daejeon, Jung-gu, Korea, Republic of Less <<
NCT02259803 Healthy Phase 1 Completed - -
NCT01237223 - Completed - -
NCT02259790 Healthy Phase 1 Completed - -
NCT01549496 Hepatitis C H... More >>ypertension Less << Phase 1 Withdrawn(Investigator left th... More >>is hospital) Less << - Canada, Ontario ... More >> Clinical Investigation Unit, Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1H8L6 Less <<
NCT01198249 Essential Hypertension Phase 1 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT01237223 Essential Hypertension Phase 3 Completed - Japan ... More >> Investigative Site Aichi, Japan Investigative Site Ehime, Japan Investigative Site Fukuoka, Japan Investigative Site Hokkaido, Japan Investigative Site Hyogo, Japan Investigative Site Kanagawa, Japan Investigative Site Kyoto, Japan Investigative Site Okayama, Japan Investigative Site Osaka, Japan Investigative Site Saitama, Japan Investigative Site Tokyo, Japan Less <<
NCT00015457 Focal Dystonia Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01631864 Hypertension ... More >>Concurrent Obesity Less << Phase 2 Completed - Germany ... More >> Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Neuss, Germany, 41460 Netherlands Novartis Investigative Site Maastricht, Netherlands, 5800 Less <<
NCT00015457 - Completed - -
NCT01842256 Essential Hypertension ... More >> Hyperlipidemia Less << Phase 1 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of Less <<
NCT02193308 Healthy Phase 1 Completed - -
NCT01631864 - Completed - -
NCT02205151 Hypertension Phase 1 Completed - Korea, Republic of ... More >> The Catholic university St. Mary hospital Seoul, Korea, Republic of, 137-701 Less <<
NCT02261064 Healthy Phase 1 Completed - -
NCT00409760 Hypertension Phase 3 Completed - Germany ... More >> Sites in Germany sites in Germany, Germany Less <<
NCT03753477 Healthy Phase 1 Completed - Korea, Republic of ... More >> Busan Paik Hospital Busan, Korea, Republic of Less <<
NCT02064621 Hypertension Phase 1 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Songpa-gu, Korea, Republic of Less <<
NCT01996449 Hypertension Not Applicable Recruiting December 2019 United States, Texas ... More >> UT Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 Contact: Debbie Arbique, DNP    214-648-3188    debbie.arbique@utsouthwestern.edu Less <<
NCT01828359 Hypertension Phase 4 Completed - -
NCT02121041 - Completed - -
NCT02710552 Arterial Hypertension Phase 4 Not yet recruiting March 2020 Italy ... More >> Sapienza University Rome, Italy, 00161 Less <<
NCT01444885 Variant Angina Phase 2 Completed - Korea, Republic of ... More >> Keimyung University Dongsan Medical Center Daegu, Korea, Republic of ChungNam Univ. Hospital DaeJeon, Korea, Republic of Gangneung Asan Hospital Gangneung, Korea, Republic of Chonnam National University Hospital Gwangju, Korea, Republic of Gyongsang National University Hospital Jinjoo, Korea, Republic of Dong-A University Hospital Pusan, Korea, Republic of Pusan National University Yansan Hospital Pusan, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Ajou University Hospital Suwon, Korea, Republic of Ulsan University Hospital Ulsan, Korea, Republic of Less <<
NCT03009474 Hypertension ... More >>Hyperlipidemias Less << Phase 1 Completed - Korea, Republic of ... More >> Korea University Anam Hospital Seoul, Korea, Republic of Less <<
NCT00241150 Hypertension ... More >>Metabolic Syndrome Less << Phase 4 Completed - -
NCT03476616 Hypertension ... More >>Obesity Less << Phase 4 Not yet recruiting September 1, 2020 Greece ... More >> Hypertension Unit, First Cardiology Clinic, Hippocration General Hospital, University of Athens, Athens, Greece Not yet recruiting Athens, Greece, 11527 Contact: Konstantinos P Tsioufis, Ass. Prof.    6932586087 ext +30    ktsioufis@hippocratio.gr    Contact: Panayiotis P Iliakis, MD    6937489286 ext +30    panayiotisiliakis@gmail.com    Principal Investigator: Konstantinos P Tsioufis, Ass. Prof.          Sub-Investigator: Kyriakos S Dimitriadis, MD, PhD          Sub-Investigator: Panayiotis P Iliakis, MD Less <<
NCT03626506 Hypertension Not Applicable Not yet recruiting December 2020 -
NCT02744456 Hypertension ... More >>High Blood Pressure Less << Phase 2 Completed - United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT03683069 Hypertension ... More >>Genetics Hypertension Less << Not Applicable Not yet recruiting August 31, 2022 -
NCT00407537 Hypertension ... More >>Hypercholesterolemia Less << Phase 4 Completed - -
NCT01041807 - Completed - -
NCT01011660 Essential Hypertension Phase 4 Unknown December 2012 China, Beijing ... More >> Wang Wen Recruiting Beijing, Beijing, China, 100037 Contact: Liyuan Ma    86 10 68335002    maliyuan600@vip.sina.com    Principal Investigator: Wen Wang Less <<
NCT00407537 - Completed - -
NCT01748253 Hypertension and Atrial Fibril... More >>lation Less << Not Applicable Unknown - Japan ... More >> Uchiyama Clinic Recruiting Joetsu city, Niigata pref., Japan Contact: Kazuaki Uchiyama    +81‐25‐548‐2400 Less <<
NCT02121041 Hypertension Not Applicable Completed - United States, North Carolina ... More >> University of North Carolina Chapel Hill, North Carolina, United States, 27599 Less <<
NCT01130168 Hypertension Phase 1 Completed - -
NCT03515772 - Recruiting October 31, 2019 Switzerland ... More >> Universitätsspital Basel Recruiting Basel, Switzerland, 4031 Contact: Catia Marzolini, PhD    +41 77 454 92 28    Catia.Marzolini@usb.ch    Centre Hospitalier Universitaire Vaudois (CHUV) Recruiting Lausanne, Switzerland, 1011 Contact: Perrine Courlet    +41 21 314 42 60    perrine.courlet@chuv.ch Less <<
NCT01271374 Hypertension Phase 4 Unknown December 2011 United States, Georgia ... More >> Atlanta Clinical Research Center Tucker, Georgia, United States, 30084 Less <<
NCT01426100 Hypertension Phase 3 Completed - Korea, Republic of ... More >> Kandong Sacred Heart Hospital Anyang, Korea, Republic of Daegu Catholic University Medical Center Daegu, Korea, Republic of Keimyung University Dongsan Medical Center Daegu, Korea, Republic of DonGuk University Ilsan Hospital Goyang, Korea, Republic of National Health Insurance Corporation Ilsan Hospital Goyang, Korea, Republic of Gachon University Gil Medical Center Inchon, Korea, Republic of Chonbuk National University Hospital Jeonju, Korea, Republic of Seoul National University Bundang Hospital Seongnam, Korea, Republic of Bundang Cha Medical Center Seoul, Korea, Republic of Ewha Womans University Hospital Seoul, Korea, Republic of Gangnam Severance Hospital Seoul, Korea, Republic of Inje University Ilsan Paik Hospital Seoul, Korea, Republic of Korea University Guro Hospital Seoul, Korea, Republic of Kyung Hee University Medical Center Seoul, Korea, Republic of Severance Hospital Seoul, Korea, Republic of Soon Chun Hyang University Hospital Seoul, Korea, Republic of St. Paul's Hospital, The catholic University of Korea Seoul, Korea, Republic of Ajou University Hospital Suwon, Korea, Republic of Less <<
NCT03662620 Hypertension Phase 1 Not yet recruiting December 23, 2018 -
NCT01337674 - Completed - -
NCT01557153 Depression Phase 3 Unknown April 2014 United Kingdom ... More >> Clinical Ageing Research Unit Not yet recruiting Newcastle upon Tyne, United Kingdom, NE4 5PL Contact: Susan Atkinson    +44(0)1912481267    susan.atkinson@ncl.ac.uk    Principal Investigator: Alan Thomas, Dr Less <<
NCT01130168 - Completed - -
NCT01316419 - Completed - -
NCT01118520 Abdominal Aortic Aneurysm Phase 2 Completed - United Kingdom ... More >> University Hospital Coventry and Warwickshire Coventry, United Kingdom, CV2 2DX Royal Free Hospital London, United Kingdom, NW3 2QG St Thomas' Hospital London, United Kingdom, SE1 7EH St Mary's Hospital, Imperial College Healthcare NHS Trust London, United Kingdom, W21PG Charing Cross Hospital, Imperial College NHS Trust London, United Kingdom, W6 8RF Less <<
NCT01316419 - Completed - -
NCT00198562 Hypertension Phase 4 Unknown March 2012 Japan ... More >> National Cardiovascular Center Suita, Osaka, Japan, 565-8565 Less <<
NCT01337674 Hypertension Phase 1 Completed - -
NCT02072330 Grade I or II Essential Hypert... More >>ension Less << Phase 2 Phase 3 Completed - Japan ... More >> Touon-shi, Ehime, Japan Fukuoka-shi, Fukuoka, Japan Hiroshima-shi, Hiroshima, Japan Sapporo-shi, Hokkaido, Japan Hanamaki-shi, Iwate, Japan Morioka-shi, Iwate, Japan Kumamoto-shi, Kumamoto, Japan Kyoto-shi, Kyoto, Japan Sendai-shi, Miyagi, Japan Osaka-shi, Osaka, Japan Suita-shi, Osaka, Japan Shinjuku-ku, Tokyo, Japan Toyama-shi, Toyama, Japan Less <<
NCT02933658 Hypertension and Dyslipidemia Phase 1 Completed - -
NCT00921570 Diabetes Hype... More >>rtension Proteinuria Less << Phase 4 Completed - Turkey ... More >> GATA Nephrology Ankara, Turkey, 06108 Less <<
NCT02121535 - Completed - -
NCT00492128 Hypertension Phase 4 Completed - Japan ... More >> Yokohama City University Graduate School of Medicine Yokohama, Kanagawa, Japan, 236-0004 Less <<
NCT02058823 Hypoxia Sleep... More >> Apnea Obstructive Sleep Apnea Less << Phase 4 Unknown December 2017 France ... More >> Laboratoire EFCR - Functional Cardio-respiratory Exploration Laboratory La Tronche, Isère, France, 38700 Less <<
NCT01128322 Hypertension Phase 2 Completed - Korea, Republic of ... More >> Hallym University Sacred Heart Hospital Anyang, Korea, Republic of Soonchunhyang University Hospital in Bucheon Bucheon, Korea, Republic of Kosin University Gospel Hospital Busan, Korea, Republic of Chungbuk National Uiversity Hospital Cheongju, Korea, Republic of Daegu Catholic University Medical Center Daegu, Korea, Republic of Keimyung University Dongsan Medical Center Daegu, Korea, Republic of DonGuk University International Hospital Goyang, Korea, Republic of National Health Insurance Corporation Ilsan Hospital Goyang, Korea, Republic of Chonnam National University Hospital Gwangju, Korea, Republic of Gachon University Gil Medical Center Inchon, Korea, Republic of Chonbuk National University Hospital Jeonju, Korea, Republic of Pusan National University Hospital Pusan, Korea, Republic of Seoul National University Bundang Hospital Seongnam, Korea, Republic of Ewha Womans University Hospital Seoul, Korea, Republic of Gangnam Severance Hospital Seoul, Korea, Republic of Kandong Sacred Heart Hospital Seoul, Korea, Republic of Korea University Guro Hospital Seoul, Korea, Republic of Kyung Hee University Medical Center Seoul, Korea, Republic of Seoul St. Mary's Hospital, The catholic University of Korea Seoul, Korea, Republic of Severance Hospital Seoul, Korea, Republic of SMG-SNU Boramae Medical Center Seoul, Korea, Republic of Soon Chun Hyang University Hospital Seoul, Korea, Republic of St. Paul's Hospital, The catholic University of Korea Seoul, Korea, Republic of Ajou University Hospital Suwon, Korea, Republic of Uijeongbu St. Mary's Hospital, The catholic University of Korea Uijeongbu, Korea, Republic of Wonju Christian Hospital Wonju, Korea, Republic of Less <<
NCT00568178 Proteinuria Phase 3 Completed - -
NCT02121535 Healthy Phase 1 Completed - Japan ... More >> Boehringer Ingelheim Investigational Site Kanagawa, Yokohama, Japan Less <<
NCT02312375 Diabetes Mellitus ... More >> Hypertension Less << Not Applicable Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-144 Less <<
NCT02206165 Essential Hypertension Phase 2 Unknown June 2015 Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam, Korea, Republic of Contact: Cheol-Ho Kim, M.D., Ph.D.          Principal Investigator: Cheol-Ho Kim, M.D., Ph.D. Less <<
NCT01243268 - Completed - Korea, Republic of ... More >> NISND Center One Or Multiple Sites, Korea, Republic of Less <<
NCT01243268 - Completed - -
NCT00568178 - Completed - -
NCT01089452 Hypertension Phase 4 Withdrawn(Study not started du... More >>e to administrative reasons.) Less << - Australia, Victoria ... More >> Alfred Hospital Melbourne, Victoria, Australia, 3004 Less <<
NCT00140959 Hypertension Phase 4 Completed - -
NCT00530946 Hypertension ... More >>Hypercholesterolemia Less << Phase 3 Completed - Japan ... More >> Pfizer Investigational Site Fukuoka-shi, Fukuoka-ken, Japan Pfizer Investigational Site Kitakyushu-shi, Fukuoka-ken, Japan Pfizer Investigational Site Kurume-shi, Fukuoka-ken, Japan Pfizer Investigational Site Maebaru-shi, Fukuoka-ken, Japan Pfizer Investigational Site Annaka, Gunma, Japan Pfizer Investigational Site Sapporo-shi, Hokkaido, Japan Pfizer Investigational Site Teine, Hokkaido, Japan Pfizer Investigational Site Yokohama-shi, Kanagawa-ken, Japan Pfizer Investigational Site Yamashita-cho, Naka-ku, Kanagawa-ken, Japan Pfizer Investigational Site Kita-ku, Osaka-fu, Japan Pfizer Investigational Site Koshigaya-shi, Saitama-ken, Japan Pfizer Investigational Site Chofu, Tokyo, Japan Pfizer Investigational Site Kiyose, Tokyo, Japan Pfizer Investigational Site Setagaya-ku, Tokyo, Japan Pfizer Investigational Site Shinagawa-Ku, Tokyo, Japan Pfizer Investigational Site Shinagawa, Tokyo, Japan Pfizer Investigational Site Osaka, Japan Less <<
NCT00202618 Hypertension ... More >>Diabetes Mellitus Albuminuria Less << Phase 4 Unknown - Japan ... More >> Shiga University of Medical Science Recruiting Otsu, Shiga, Japan, 520-2192 Contact: Atsunori Kashiwagi, Professor    81-77-548-2221    kasiwagi@belle.shiga-med.ac.jp    Contact: Hiroshi Maegawa, A. Professor    81-77-548-2222    maegawa@belle.shiga-med.ac.jp    Principal Investigator: Hiroshi Maegawa          Principal Investigator: Yasuo Kida          Principal Investigator: Shu Yamada          Principal Investigator: Masataka Nishimura          Principal Investigator: Tetsuro Arimura          Principal Investigator: Noriko Takahara          Principal Investigator: Katsuya Egawa          Principal Investigator: Masanori Iwanishi          Principal Investigator: Toshiki Fujita          Principal Investigator: Aya Kadota Less <<
NCT01344629 Healthy Phase 1 Completed - Japan ... More >> 1235.28.001 Boehringer Ingelheim Investigational Site Kumamoto, Kumamoto, Japan Less <<
NCT01819779 Healthy Male Subjects Phase 1 Completed - Korea, Republic of ... More >> Metro Hospital Anyang, Kyung Gi, Korea, Republic of, 430-720 Less <<
NCT01344629 - Completed - -
NCT00219154 Hypertension Phase 3 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT03722524 - Not yet recruiting February 28, 2019 Russian Federation ... More >> FSBI NMIC of Cardiology of the Ministry of Health of Russia Moscow, Russian Federation, 121552 Less <<
NCT00530946 - Completed - -
NCT00819104 Primary Hypertension Phase 4 Completed - India ... More >> Research Site Hyderabad, Andhra Pradesh, India Research Site Ahmedabad, Gujarat, India Research Site Bangalore, Karnataka, India Research Site Calicut, Kerala, India Research Site Mumbai, Maharashtra, India Research Site Poona, Maharashtra, India Research Site Jaipur, Rajasthan, India Research Site Lucknow, Uttar Pradesh, India Research Site Kolkata, West Bengal, India Research Site Bangalore, India Research Site Delhi, India Less <<
NCT00412113 - Completed - -
NCT00170950 Hypertension Phase 3 Terminated(The study was termi... More >>nated early because of significant efficacy results for the primary endpoint in favor of benazepril/amlodipine treatment.) Less << - United States, New Jersey ... More >> Novartis Pharmaceuticals E. Hanover, New Jersey, United States, 07936 Denmark sites in Denmark Denmark, Denmark Finland sites in Finland Finland, Finland Norway sites in Norway Norway, Norway Sweden sites in Sweden Sweden, Sweden Less <<
NCT00412113 Dyslipidemia ... More >>Hypertension Less << Phase 4 Completed - -
NCT02213224 Nonalcoholic Fatty Liver Disea... More >>se (NAFLD) Less << Phase 4 Unknown September 2017 China, Guangdong ... More >> Nanfang Hospital, Southern Medical University Recruiting GuangZhou, Guangdong, China, 510515 Contact: Yue Li, MD    +86-15975537291    liyue_1989919@126.com    Principal Investigator: Side Liu, MD.PhD          Sub-Investigator: Yue Li, MD          Sub-Investigator: Xu Li, MD          Sub-Investigator: Zelong Han, MD          Sub-Investigator: Wen Xu, MM          Sub-Investigator: Yubin Guo, MM          Sub-Investigator: Feng Xiong, MD Less <<
NCT00091429 Angina Phase 3 Completed - -
NCT00170950 - Terminated(The study was termi... More >>nated early because of significant efficacy results for the primary endpoint in favor of benazepril/amlodipine treatment.) Less << - -
NCT02896621 Hypertension ... More >>Sleep Apnea Less << Phase 3 Completed - Brazil ... More >> Hospital de Clinicas de Porto Alegre Porto Alegre, RS, Brazil, 90035-903 Less <<
NCT00171561 Hypertension Phase 4 Completed - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT02962336 Healthy Subjects Phase 1 Completed - -
NCT02060019 Healthy Phase 1 Completed - Korea, Republic of ... More >> Kyungpook university hospital Deagu, Korea, Republic of Less <<
NCT02378064 Inflammation Plaque, Atheroscl... More >>erotic Coronary Disease Renin-Angiotensin System Less << Phase 4 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less <<
NCT02140489 Healthy Phase 1 Unknown August 2014 Korea, Republic of ... More >> Samgsung Seoul Hospital Recruiting Seoul, Korea, Republic of Principal Investigator: JaeWook Ko, M.D. Less <<
NCT02665832 Healthy Phase 1 Unknown June 2016 -
NCT00818779 Coronary Artery Disease ... More >> Type 2 Diabetes Mellitus Less << Phase 4 Completed - United States, Texas ... More >> Texas Tech University Health Sciences Center Lubbock, Texas, United States, 79430 Less <<
NCT03536598 Hypertension With Hyperlipidem... More >>ia Less << Phase 3 Completed - -
NCT00818779 - Completed - -
NCT01634295 Hypertension Phase 3 Completed - Korea, Republic of ... More >> Seoul national university Bundang Hospital Bundang-gu, Gyeonggi-do, Korea, Republic of, 463-707 Less <<
NCT00867490 - Completed - -
NCT00656331 Hypertension Not Applicable Terminated June 2012 United States, New Mexico ... More >> UNMHSC Albuquerque, New Mexico, United States, 87131 Less <<
NCT02046395 Type 2 Diabetes ... More >> Hypertension Less << Phase 4 Recruiting December 2019 United States, Louisiana ... More >> Tulane University Health Sciences Center Recruiting New Orleans, Louisiana, United States, 70112 Contact: Bonnie L Katalenich, MPH    504-988-0200    bkatalen@tulane.edu    Principal Investigator: Tina Thethi, MD, MPH Less <<
NCT03635125 JNC 7 Stage 1 or 2 Hypertensio... More >>n Less << Phase 4 Completed - United States, Texas ... More >> Punzi Medical Center Carrollton, Texas, United States, 75006 Less <<
NCT01762501 Hypertension Not Applicable Completed - -
NCT00867490 Hypertension Phase 3 Completed - Germany ... More >> Investigative Site Chemnitz, Germany Less <<
NCT01762501 - Completed - -
NCT00333489 Hypertension Phase 4 Completed - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00351130 Hypertension Phase 4 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00716950 Essential Hypertension Phase 4 Unknown February 2009 Italy ... More >> Giuseppe Derosa Recruiting Pavia, Italy, 27100 Contact: Giuseppe Derosa, MD    +39 0382 502614    giuseppe.derosa@unipv.it    Principal Investigator: Giuseppe Derosa, MD, PhD Less <<
NCT02710539 Arterial Hypertension Phase 4 Not yet recruiting March 2020 Italy ... More >> University La Sapienza Rome, Italy, 00166 Less <<
NCT01983735 Hypertension Phase 3 Unknown August 2014 Korea, Republic of ... More >> The catholic university of Korea Seoul St. Mary's hospital Not yet recruiting Seoul, Korea, Republic of Contact: Ho-Joong Yoon, Ph.D    82-2-2258-6029    younhj@catholic.ac.kr    Principal Investigator: Ho-Joong Yoon, Ph.D Less <<
NCT00337298 Type 1 Diabetes ... More >> Diabetic Retinopathy Eye Diseases Diabetes Complications Less << Not Applicable Completed - Denmark ... More >> Aarhus university hospital Aarhus, Denmark, 8000 Less <<
NCT03205137 - Not yet recruiting February 28, 2019 -
NCT00693199 Lower Urinary Tract Symptoms ... More >> Hypertension Less << Not Applicable Completed - China, Anhui ... More >> Biomedicine Inistitute of Anhui Medical University Hefei, Anhui, China, 230032 Less <<
NCT00558428 Hypertension Phase 3 Completed - -
NCT01838850 Essential Hypertension Phase 3 Completed - Korea, Republic of ... More >> Korea University Ansan Hospital Ansan, Korea, Republic of, 425-707 Hallym University Medical Center Anyang, Korea, Republic of, 431-796 Soonchunhyang University Hospital Bucheon, Korea, Republic of, 420-767 Dong-A University Hospital Busan, Korea, Republic of, 602-715 Pusan National University Hospital Busan, Korea, Republic of, 602-739 Daedong Hospital Busan, Korea, Republic of, 607-711 Inje University Haeundae Paik Hospital Busan, Korea, Republic of, 612-896 Inje University Busan Paik Hospital Busan, Korea, Republic of, 614-735 Chungbuk National University Hospital Cheongju, Korea, Republic of, 361-711, Presbyterian Medical Center Cheonju, Korea, Republic of, 560-750 Chonbuk National University Hospital Cheonju, Korea, Republic of, 561-712 Keimyung University Dongsan Medical Center Daegu, Korea, Republic of, 700-712 Daegu Catholic University Medical Center Daegu, Korea, Republic of, 705-718 Chungnam National University Hospital Daejeon, Korea, Republic of, 301-721 Konyang University Hospital Daejeon, Korea, Republic of, 302-718 Health Insurance Service Ilsan Hospital Goyang, Korea, Republic of, 410-719 Hanyang University Guri Hospital Guri, Korea, Republic of, 471-701 Chonnam National University Hospital Gwangju, Korea, Republic of, 501-757 Gachon University Gil Medical Center Incheon, Korea, Republic of, 405-835 Seoul National University Bundang Hospital Seongnam, Korea, Republic of, 463-707 Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Severance Hospital Seoul, Korea, Republic of, 120-752 Kyung Hee University Medical Center Seoul, Korea, Republic of, 130-702 Kyunghee University Hospital at Gandong Seoul, Korea, Republic of, 134-727 Seoul Veterans Hospital Seoul, Korea, Republic of, 134-791 Sanmsung Medical Center Seoul, Korea, Republic of, 135-710 Gangnam Severance Hospital Seoul, Korea, Republic of, 135-720 Korea University Anam Hospital Seoul, Korea, Republic of, 136-705 Seoul St. Mary's Hospital of the Catholic University of Korea Seoul, Korea, Republic of, 137-701 Asan Medical Center Seoul, Korea, Republic of, 138-736 Eulji General Hospital Seoul, Korea, Republic of, 139-711 Konkuk University Medical Center Seoul, Korea, Republic of, 143-729 Yeouido St. Mary's Hospital of the Catholic University of Korea Seoul, Korea, Republic of, 150-713 Korea University Guro Hospital Seoul, Korea, Republic of, 152-840 Chung-Ang University Hospital Seoul, Korea, Republic of, 156-755 St. Carollo Hospital Suncheon, Korea, Republic of, 540-719 Ajou University Hospital Suwon, Korea, Republic of, 443-380 Ulsan University hospital Ulsan, Korea, Republic of, 682-714 Wonju Severance Christian Hospital Wonju, Korea, Republic of, 220-701 Less <<
NCT01302691 Hypertension Phase 3 Completed - -
NCT01103960 - Completed - -
NCT01103960 Hypertension Phase 3 Completed - China ... More >> 1235.29.86001 Boehringer Ingelheim Investigational Site Beijing, China 1235.29.86004 Boehringer Ingelheim Investigational Site Beijing, China 1235.29.86006 Boehringer Ingelheim Investigational Site Changchun, China 1235.29.86013 Boehringer Ingelheim Investigational Site Changsha, China 1235.29.86014 Boehringer Ingelheim Investigational Site Guangzhou, China 1235.29.86012 Boehringer Ingelheim Investigational Site Hangzhou, China 1235.29.86002 Boehringer Ingelheim Investigational Site Shanghai, China 1235.29.86009 Boehringer Ingelheim Investigational Site Shanghai, China 1235.29.86010 Boehringer Ingelheim Investigational Site Shanghai, China 1235.29.86011 Boehringer Ingelheim Investigational Site Shanghai, China 1235.29.86007 Boehringer Ingelheim Investigational Site Shenyang, China 1235.29.86008 Boehringer Ingelheim Investigational Site Tianjin, China Malaysia 1235.29.60017 Boehringer Ingelheim Investigational Site Johor, Malaysia 1235.29.60016 Boehringer Ingelheim Investigational Site Kuala Lumpur, Malaysia Philippines 1235.29.63018 Boehringer Ingelheim Investigational Site Metro Manila, Philippines 1235.29.63019 Boehringer Ingelheim Investigational Site Quezon City, Philippines Less <<
NCT01603940 Hypertension ... More >>Diabetes Mellitus Less << Phase 4 Completed - Brazil ... More >> Hospital Universitario Pedro Ernesto Rio de Janeiro, RJ, Brazil, 20551030 Less <<
NCT01302691 - Completed - -
NCT00558428 - Completed - -
NCT00242814 Hypertension ... More >>Metabolic Syndrome X Less << Phase 4 Completed - France ... More >> 502.486.3302A Cabinet Médical Angers, France 502.486.3302B Cabinet Médical Angers, France 502.486.3303A Boehringer Ingelheim Investigational Site Angers, France 502.486.3305A Cabinet Médical Angers, France 502.486.3323A Cabinet Médical Angers, France 502.486.3323B Cabinet Médical Angers, France 502.486.3324A Cabinet Médical Angers, France 502.486.3324B Cabinet Médical Angers, France 502.486.3325A Cabinet médical Angers, France 502.486.3326A Cabinet Médical Angers, France 502.486.3328A Cabinet Médical Angers, France 502.486.3306A Cabinet Médical Briollay, France 502.486.3307A Cabinet Médical Chemille, France 502.486.3319A Cabinet Médical Cherbourg, France 502.486.3320A Cabinet Médical Cherbourg, France 502.486.3320B Cabinet Médical Cherbourg, France 502.486.3321A Cabinet Médical Equeurdreville, France 502.486.3322A Boehringer Ingelheim Investigational Site Evron, France 502.486.3312A Cabinet Médical Feneu, France 502.486.3315A Cabinet Médical La Rochelle, France 502.486.3308A Cabinet Médical Montrevault, France 502.486.3316A Boehringer Ingelheim Investigational Site Nieul sur Mer, France 502.486 3301A Boehringer Ingelheim Investigational Site Paris, France 502.486.3301B Hôpital Pitié Salpêtrière Paris, France 502.486.3310A Cabinet Médical Saint Pierre Montlimard, France 502.486.3327A Cabinet Médical Saumur, France 502.486.3309A Cabinet Médical Jean Charcot Segre, France 502.486.3311A Cabinet Médical Tierce, France 502.486.3311B Cabinet Médical Tierce, France 502.486.3311C Cabinet Médical Tierce, France 502.486.3311D Cabinet Médical Tierce, France Less <<
NCT00220233 Essential Hypertension Phase 3 Completed - Germany ... More >> Leipzig, Germany Sinsheim, Germany Tann, Germany Weinheim, Germany Wiesbaden, Germany Less <<
NCT01922141 Hypertension Phase 4 Withdrawn June 2018 -
NCT00240474 Hypertension Phase 4 Completed - -
NCT02995954 Hypertension Phase 4 Completed - Italy ... More >> San Giovanni e Ruggi Hospital Salerno, Italy, 84100 Less <<
NCT01975246 Hypertension Phase 3 Completed - Japan ... More >> 1348.1.015 Boehringer Ingelheim Investigational Site Atsubetsu-ku,Sapporo,Hokkaido, Japan 1348.1.006 Boehringer Ingelheim Investigational Site Bunkyo-ku, Tokyo, Japan 1348.1.002 Boehringer Ingelheim Investigational Site Chiyoda-ku, Tokyo, Japan 1348.1.005 Boehringer Ingelheim Investigational Site Chiyoda-ku, Tokyo, Japan 1348.1.031 Boehringer Ingelheim Investigational Site Chiyoda-ku, Tokyo, Japan 1348.1.030 Boehringer Ingelheim Investigational Site Chuo-ku, Tokyo, Japan 1348.1.033 Boehringer Ingelheim Investigational Site Chuo-ku, Tokyo, Japan 1348.1.016 Boehringer Ingelheim Investigational Site Chuo-ku,Sapporo,Hokkaido, Japan 1348.1.021 Boehringer Ingelheim Investigational Site Chuo-ku,Tokyo, Japan 1348.1.024 Boehringer Ingelheim Investigational Site Itabashi-ku, Tokyo, Japan 1348.1.028 Boehringer Ingelheim Investigational Site Itoshima, Fukuoka, Japan 1348.1.027 Boehringer Ingelheim Investigational Site Katsushika-ku, Tokyo, Japan 1348.1.001 Boehringer Ingelheim Investigational Site Kishiwada, Osaka, Japan 1348.1.009 Boehringer Ingelheim Investigational Site Kita-ku, Osaka, Japan 1348.1.029 Boehringer Ingelheim Investigational Site Kita-ku, Osaka, Japan 1348.1.014 Boehringer Ingelheim Investigational Site Kiyose,Tokyo, Japan 1348.1.003 Boehringer Ingelheim Investigational Site Koto-ku, Tokyo, Japan 1348.1.022 Boehringer Ingelheim Investigational Site Mihama-ku, Chiba, Chiba, Japan 1348.1.004 Boehringer Ingelheim Investigational Site Miyagino-ku, Sendai, Miyagi, Japan 1348.1.017 Boehringer Ingelheim Investigational Site Moriya, Ibaraki, Japan 1348.1.013 Boehringer Ingelheim Investigational Site Naka-ku,Yokohama,Kanagawa, Japan 1348.1.018 Boehringer Ingelheim Investigational Site Nishi-ku, Fukuoka, Fukuoka, Japan 1348.1.007 Boehringer Ingelheim Investigational Site Okinawa, Okinawa, Japan 1348.1.020 Boehringer Ingelheim Investigational Site Sakaide, Kagawa, Japan 1348.1.025 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1348.1.026 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1348.1.008 Boehringer Ingelheim Investigational Site Suita, Osaka, Japan 1348.1.032 Boehringer Ingelheim Investigational Site Suita, Osaka, Japan 1348.1.019 Boehringer Ingelheim Investigational Site Takamatsu, Kagawa, Japan 1348.1.023 Boehringer Ingelheim Investigational Site Toshima-ku, Tokyo, Japan Less <<
NCT03639480 Hypertension ... More >>Hyperlipidemia Less << Phase 3 Enrolling by invitation October 2018 Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less <<
NCT00157963 Essential Hypertension Phase 4 Completed - -
NCT01975246 - Completed - -
NCT03648333 Healthy Male Subjects Phase 1 Completed - -
NCT00129233 Hypertension ... More >>Type 2 Diabetes Mellitus Less << Phase 4 Completed - Japan ... More >> Department of Cardiology, Nagoya University Graduate School of Medicine Nagoya, Aichi, Japan, 466-8550 Less <<
NCT00143195 Myocardial Ischemia Phase 4 Completed - Greece ... More >> Pfizer Investigational Site Athens, Attika, Greece, 11527 Pfizer Investigational Site Athens, Greece, 123 51 Pfizer Investigational Site Athens, Greece Pfizer Investigational Site Holargos/Athens, Greece, 11525 Pfizer Investigational Site Loannina, Greece, 45500 Pfizer Investigational Site N. Ionia, Greece, 143 88 Pfizer Investigational Site Patra, Greece, 26335 Pfizer Investigational Site Rio, Patra, Greece, 26499 Pfizer Investigational Site Thessaloniki, Greece, 546 36 Pfizer Investigational Site Thessaloniki, Greece, 54639 Pfizer Investigational Site Voula/Athens, Greece Pfizer Investigational Site Zakynthos, Greece, 29100 Less <<
NCT00219115 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany Less <<
NCT03629067 Pharmacokinetics Phase 1 Not yet recruiting February 2019 Korea, Republic of ... More >> Seoul National University Hospital Not yet recruiting Seoul, Jongno-gu, Korea, Republic of, 100-744 Contact: Kyung-sang Yu    82-2-2072-1920    ksyu@snu.ac.kr Less <<
NCT03082014 Cerebral Small Vessel Diseases Phase 3 Recruiting September 30, 2020 Germany ... More >> Insitute for Stroke and Dementia Research Not yet recruiting Munich, Germany, 81377 Contact: Martin Dichgans, Prof.    +49 89 4400 ext 46019       Contact: Anna Kopczak, MD    +49 89 4400 ext 46125       Netherlands Maastricht University Medical Center Not yet recruiting Maastricht, Netherlands, 6202 AZ Contact: Robert van Oostenbrugge, Prof.          Contact: Julie Staals, MD, PhD          Sub-Investigator: Danielle Kerkhofs          University Medical Center Utrecht Not yet recruiting Utrecht, Netherlands, 3584 CX Contact: Geert Jan Biessels, Prof.          Contact: Hilde van den Brink, MD          United Kingdom Nuffield Department of Clinical Neurosciences Recruiting Oxford, England, United Kingdom, OX1 2JD Contact: Peter Rothwell, Prof.          Contact: Alastair Webb, MD, PhD          Centre for Clinical Brain Sciences Not yet recruiting Edinburgh, Scotland, United Kingdom, EH16 4SB Contact: Joanna Wardlaw, Prof.          Contact: Fergus Doubal, MD, PhD Less <<
NCT01603940 - Completed - -
NCT00156403 Pancreatitis Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> General Clinical Research Center, University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00294710 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany Less <<
NCT00950066 Hypertension Phase 2 Completed - India ... More >> Sanofi-Aventis Administrative Office Mumbai, India Korea, Republic of Sanofi-Aventis Administrative Office Seoul, Korea, Republic of Philippines Sanofi-Aventis Administrative Office Makati City, Philippines Taiwan Sanofi-Aventis Administrative Office Taipei, Taiwan Less <<
NCT00313547 Hypertension Phase 4 Terminated(Very difficult to r... More >>ecruit patients/slow recruitment(2 patients in nearly 2 years).) Less << - Canada, Quebec ... More >> Montreal Heart Institute Montreal, Quebec, Canada, H1T 1C8 Less <<
NCT00789321 Hypertension Phase 1 Completed - -
NCT01222520 - Completed - -
NCT00219076 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States Germany Investigative Centers, Germany Less <<
NCT00171535 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00185133 Hypertension Phase 3 Completed - -
NCT01222520 Hypertension Phase 3 Completed - Japan ... More >> 1235.36.01 Boehringer Ingelheim Investigational Site Chuo-ku,Tokyo, Japan 1235.36.04 Boehringer Ingelheim Investigational Site Hiroshima, Hiroshima, Japan 1235.36.02 Boehringer Ingelheim Investigational Site Shinjuku-ku, Tokyo, Japan 1235.36.03 Boehringer Ingelheim Investigational Site Suita, Osaka, Japan Less <<
NCT00789321 - Completed - -
NCT01299376 Hypertension Phase 3 Completed - -
NCT00813722 Blood Pressure Phase 4 Unknown June 2009 Brazil ... More >> Sao Paulo University Sao Paulo, Brazil, 05403-900 University of Sao Paulo Sao Paulo, Brazil, 05405-000 Less <<
NCT03461003 Pediatric Hypertension Phase 4 Recruiting January 2020 United States, Texas ... More >> The University of Texas Health Science Center at Houston Recruiting Houston, Texas, United States, 77030 Contact: Joyce P Samuel, MD, MS    713-500-5670    joyce.p.samuel@uth.tmc.edu Less <<
NCT02850081 Carotid Artery Stenosis ... More >> Strokes Less << Phase 3 Recruiting April 2022 United States, New Jersey ... More >> Valley Hospital Not yet recruiting Ridgewood, New Jersey, United States, 07450 Contact: Avery Freed    201-389-0194    afreed@valleyhealth.com    Contact: Kathleen Sayles       KSAYLES@valleyhealth.com    Principal Investigator: Dorothea Altschul, MD          United States, New York Albany Medical College/The Vascular Group at Albany Not yet recruiting Albany, New York, United States, 12208-3479 Contact: Ryan Kaim       KaimR@mail.amc.edu    Contact: Angela Sheehan       SheehaA@mail.amc.edu    Principal Investigator: Courtney Warner, MD          Sub-Investigator: Ralph C Darling, MD          State University of New York at Buffalo Not yet recruiting Buffalo, New York, United States, 14260-7016 Contact: Jennifer Gay    716-440-4231    jgay@ubns.com    Contact: Reagan O'Toole       rotoole@ubns.com    Principal Investigator: Adnan Siddiqui, MD          New York University School of Medicine Not yet recruiting New York, New York, United States, 10016-6402 Contact: Jacqueline Bott    212-263-2268    jacqueline.bott@nyumc.org    Principal Investigator: Thomas Maldonado, MD          Icahn School of Medicine at Mount Sinai Not yet recruiting New York, New York, United States, 10029 Contact: Rebecca Apruzzese    212-241-8349    rebecca.apruzzese@mountsinai.org    Contact: Milerva Santos       milerva.santos@mountsinai.org    Principal Investigator: J Mocco, MD          Sub-Investigator: Emilia Bagiella, MD          Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Rebeca Aragon Garcia, BS    212-305-4679    ra2356@cumc.columbia.edu    Contact: Josephine U Pucci, BA    21123054679    jup2102@cumc.columbia.edu    Principal Investigator: Edward S Connolly, MD          Sub-Investigator: Elise A Caccappolo Van Vliet, PhD          Sub-Investigator: Yaakov Stern, MD          Sub-Investigator: Richard Buchsbaum          Sub-Investigator: Eric J Heyer, MD          Sub-Investigator: Erin L Heinzen-Cox, PhD          Cornell University Medical College (Weill) Not yet recruiting New York, New York, United States, 10065-4805 Contact: Ruchita Mehta       rum2006@med.cornell.edu    Principal Investigator: Peter Connolly, MD Less <<
NCT01567774 Coronary Artery Disease Phase 4 Unknown June 2015 Italy ... More >> Sapienza University Recruiting Rome, Italy, 00161 Contact: Francesco Pelliccia, MD    064997 ext 123    f.pelliccia@mclink.it    Principal Investigator: Francesco Pelliccia, MD          University Sapienza Not yet recruiting Rome, Italy, 00166 Contact: Francesco Pelliccia, MD    +3906499 ext 123    f.pelliccia@mclink.it Less <<
NCT03489317 - Recruiting December 2021 Hong Kong ... More >> Department of Microbiology, Chinese University of Hong Kong Recruiting Sha Tin, Hong Kong Contact: Yun Kit Yeoh    85235053333    yeohyunkit@cuhk.edu.hk    Lek Yuen Health Centre Recruiting Sha Tin, Hong Kong Contact: Martin Wong    85222528782    wong_martin@cuhk.edu.hk Less <<
NCT01299376 - Completed - -
NCT01692301 Hypertension Phase 2 Completed - -
NCT00125463 Hypertension ... More >>Cardiovascular Diseases Less << Phase 3 Unknown - Japan ... More >> Kyoto University Kyoto, Yoshidakonoe-cho, Sakyo-ku, Kyoto, Japan, 606-8501 Less <<
NCT02955498 Healthy Male Subjects Phase 1 Completed - Korea, Republic of ... More >> Metrohospital Anyang, Kyung Gi, Korea, Republic of, 430-720 Less <<
NCT00518479 Hypertension ... More >>Left Ventricular Hypertrophy Less << Not Applicable Completed - United Kingdom ... More >> Leeds Teaching Hospital NHS Trust Leeds, Wesst Yorkshire, United Kingdom, LS1 3EX Less <<
NCT02795910 Diabetes Mellitus ... More >> Hypertension Heart Failure Ischemic Heart Disease Cerebrovascular Disease Less << Not Applicable Active, not recruiting March 31, 2019 Brazil ... More >> Florianopolis City Health Department Florianopolis, Santa Catarina, Brazil, 88.040-400 Less <<
NCT01692301 - Completed - -
NCT01677767 - Completed - -
NCT00000620 Atherosclerosis ... More >> Cardiovascular Diseases Hypercholesterolemia Hypertension Diabetes Mellitus, Type 2 Diabetes Mellitus Coronary Disease Less << Phase 3 Completed - United States, Minnesota ... More >> Minneapolis Medical Research Foundation Minneapolis, Minnesota, United States, 55404 United States, New York Columbia University New York, New York, United States, 10027 United States, North Carolina Wake Forest University Winston-Salem, North Carolina, United States, 27106 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Tennessee Veterans Affairs Memphis, Tennessee, United States, 38104 United States, Washington University of Washington Seattle, Washington, United States, 98195 Canada, Ontario McMaster University Hamilton, Ontario, Canada Less <<
NCT00661895 Hypertension Phase 4 Completed - United States, Nebraska ... More >> Creighton Community Health Center Omaha, Nebraska, United States, 68104 Less <<
NCT00563901 - Completed - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Texas University of Texas Houston Houston, Texas, United States, 77030 Less <<
NCT02348658 Hypertension Phase 1 Completed - Japan ... More >> Fukuoka-shi, Fukuoka, Japan Less <<
NCT01677767 - Completed - India ... More >> Sir Gangaram Hospital New Delhi, Delhi, India, 110060 Ahmedabad Dialysis Centre Ahmedabad, India, 380005 Excel Center Guwahati, India, 781007 ESIS Hospital; Department of Nephrology Kolkata, India, 600054 Vertex Hospital Mumbai, India, 400083 Apollo Indraprastha Hospitals; Nephrology New Delhi, India, 110076 Aditya Birla Memorial Hospital Pune, India, 411033 Less <<
NCT02348658 - Completed - -
NCT00081731 - Completed - -
NCT00000620 - Completed - -
NCT00753636 Parkinson's Disease Phase 2 Completed - United States, Illinois ... More >> 710 N. Lake Shore Dr. Chicago, Illinois, United States, 60610 Less <<
NCT00935805 - Unknown July 2012 Brazil ... More >> Hospital de Clínicas de Porto Alegre Porto Alegre, RS, Brazil, 90035-903 Less <<
NCT00753636 - Completed - -
NCT00081731 Atherosclerosis ... More >> Cardiovascular Diseases Hypertension, Renovascular Renal Artery Obstruction Less << Phase 3 Completed - United States, Ohio ... More >> University of Toledo Toledo, Ohio, United States, 43614 Less <<
NCT01083017 - Completed - Switzerland ... More >> Geneva University Hospitals Geneva, Switzerland Lausanne University Hospital, CHUV Lausanne, Switzerland Kantonsspital Luzern Luzern, Switzerland Less <<
NCT00000542 Cardiovascular Diseases ... More >> Coronary Disease Diabetes Mellitus Heart Diseases Hypercholesterolemia Hypertension Myocardial Infarction Myocardial Ischemia Heart Failure Less << Phase 3 Completed - -
NCT00741585 Essential Hypertension ... More >> Cardiovascular Disease Stroke Chronic Kidney Disease Less << Phase 4 Completed - Spain ... More >> CS Friol Friol, Lugo, Spain, 27220 CS Baiona Baiona, Pontevedra, Spain, 36300 CS Bueu Bueu, Pontevedra, Spain, 36930 CS A Estrada La Estrada, Pontevedra, Spain, 26680 CS A Guarda La Guardia, Pontevedra, Spain, 36780 CS Valmiñor Nigran, Pontevedra, Spain, 36250 CS Panxón Nigrán, Pontevedra, Spain, 36340 CS Tomiño Tomiño, Pontevedra, Spain, 36200 Bioengineering & Chronobilogy Labs., University of Vigo Vigo, Pontevedra, Spain, 36200 Hospital do Meixoeiro Vigo, Pontevedra, Spain, 36200 CS Calle Cuba Vigo, Pontevedra, Spain, 36202 CS A Doblada Vigo, Pontevedra, Spain, 36205 CS Coia Vigo, Pontevedra, Spain, 36209 CS Sardoma Vigo, Pontevedra, Spain, 36214 CS Teis Vigo, Pontevedra, Spain, 36216 CS Vilaboa Vilaboa, Pontevedra, Spain, 36141 CS San Roque Vilagarcía De Arousa, Pontevedra, Spain, 36600 CS Fingoi Lugo, Spain, 27002 Complexo Hospitalario Universitario de Ourense Orense, Spain, 32005 CS Lerez Pontevedra, Spain, 36156 Less <<
NCT00000522 Cardiovascular Diseases ... More >> Heart Diseases Hypertension Vascular Diseases Less << Phase 2 Completed - -
NCT01631409 - Withdrawn(The study has been w... More >>ithdrawn due to organizational problems) Less << September 2021 -
NCT03024476 Ischemic Stroke ... More >> Hypertension Less << Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Gyeonggi, Korea, Republic of, 13520 Nowon Eulji Medical Center, Eulji University Seoul, Korea, Republic of, 01830 Seoul Medical Center Seoul, Korea, Republic of, 02053 Less <<
NCT01996085 Arterial Hypertension Not Applicable Completed - Poland ... More >> Military Institute of Medicine Warsaw, Mazovia, Poland, 04-141 Less <<
NCT00535925 Diabetic Nephropathy Phase 4 Unknown September 2012 Italy ... More >> Department of Clinical and Experimental Medicine, Second University of Naples Naples, Italy, I-80131 Less <<
NCT00332761 Hypertension ... More >>Dyslipidemia Less << Phase 4 Completed - -
NCT01536353 Hypertension Phase 1 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less <<
NCT02539810 Hypertension ... More >>Hypertension Resistant to Conventional Therapy Angiographically Proven Grade III Unilateral or Bilateral Atherosclerotic Renal Artery Stenosis (ARAS) Greater Than or Equal to 60 Percent Less << Phase 4 Terminated - France ... More >> Hopital Pasteur Nice, Alpes-Maritimes, France, 06002 Hopital Saint Andre - CHU Bordeaux Bordeaux, Gironde, France, 33075 Hopital Rangueil - CHU Toulouse Toulouse, Haute-Garonne, France, 31059 Hopital Lapeyronie - CHU Montpellier Montpellier, Herault, France, 34295 Hopital Arthur Gardiner Dinard, Ille-et-Vilaine, France, 35800 Hopital Pontchaillou - CHU Rennes Rennes, Ille-et-Vilaine, France, 35033 Groupe Hospitalier Mutualiste Grenoble, Isere, France, 38028 Hopital Michallon - CHU Grenoble La Tronche, Isere, France, 38700 Institut Lorrain du Cœur et des Vaisseaux Louis Mathieu Vandoeuvre les Nancy, Meurthe-et-Moselle, France, 54500 Hopital de Brabois Vandoeuvre les Nancy, Meurthe-et-Moselle, France, 54511 Hopital Cardiologique - CHRU Lille Lille, Nord, France, 59037 CHU Clermont-Ferrand Clermont-Ferrand, Puy-de-Dome, France, 63000 Hopital de la Croix-Rousse - CHU Lyon Lyon, Rhone, France, 69004 Hopital de la Pitie Salpetriere Paris, France, 75013 Hopital Europeen Georges Pompidou (HEGP) Paris, France, 75015 Less <<
NCT02094469 Vasospastic Angina Phase 3 Completed - Korea, Republic of ... More >> Yangsan Busan University Hospital Busan, Korea, Republic of, 626-770 Less <<
NCT02513927 Hypertension Phase 2 Phase 3 Unknown October 2018 Hungary ... More >> Twenty-four-hour ambulatory BP monitoring Recruiting Budapest, Hungary Contact: Jingyan Piao, MM    86-451-85555333    411483521@qq.com    Contact: Yujiao Pan, MM    86-451-85555671    panyujiao@163.com Less <<
NCT00744237 Hypertension ... More >>Type 2 Diabetes Mellitus Less << Phase 4 Completed - -
NCT00744237 - Completed - -
NCT02563405 Hypertension Phase 2 Phase 3 Unknown October 2018 China, Heilongjiang ... More >> uric acid test and 24-hour ambulatory BP monitoring Recruiting Harbin, Heilongjiang, China, 150001 Contact: Yujiao Pan, MM    86-451-85555671    panyujiao@163.com Less <<
NCT03147092 Hypertension ... More >>Blood Pressure Less << Early Phase 1 Not yet recruiting June 30, 2021 -
NCT00631514 Hypertension Phase 4 Completed - Croatia ... More >> Split University School of Medicine. Family Practice Department Split, Croatia, 21000 Less <<
NCT03660397 Uncontrolled Hypertension Phase 3 Recruiting January 1, 2020 China, Chongqing ... More >> The third hospital affiliated to the Third Military Medical University Recruiting Chongqing, Chongqing, China, 400042 Contact: Hongbo He, MD.    86-23-68757880    cqhehongbo@gmail.com    Principal Investigator: Zhiming Zhu, MD. Less <<
NCT00745953 Metabolic Syndrome ... More >> Lipotoxicity Less << Phase 4 Unknown August 2009 United States, Texas ... More >> University of Texas Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 Less <<
NCT03319823 High Blood Pressure Phase 4 Recruiting December 1, 2018 United States, California ... More >> Cedars-Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Contact: Katie Sy    310-248-7641    katrina.sy@cshs.org    Principal Investigator: Ronald G Victor, MD Less <<
NCT03504735 Metabolic Syndrome Phase 4 Completed - -
NCT01432106 Hypertension ... More >>Metabolic Syndrome Less << Phase 1 Withdrawn(Novartis terminated ... More >>all projects involving aliskiren. Findings of the DMC overseeing the ALTITUDE clinical trial found a higher incidence of adverse events.) Less << - United States, Michigan ... More >> University of Michigan Health System Ann Arbor, Michigan, United States, 48106 Less <<
NCT01994408 Hypertension Phase 1 Phase 2 Terminated(slow enrollment) - United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 Less <<
NCT01984164 Hypertension ... More >>Mild Cognitive Impairment Less << Phase 3 Active, not recruiting December 15, 2018 United States, Georgia ... More >> Emory Univeristy Atlanta, Georgia, United States, 30329 Less <<
NCT00994253 Hypertension ... More >>Diabetes Type 2 Less << Phase 4 Withdrawn(Due to safety concer... More >>ns re the concomitant use of aliskiren with an ACEi or ARB.) Less << December 2012 United States, Michigan ... More >> William Beaumont Hospital Royal Oak, Michigan, United States, 48073 Less <<
NCT03640312 Hypertension Phase 2 Not yet recruiting December 1, 2021 -
NCT02364089 Adrenal Incidentalomas Not Applicable Recruiting December 2021 France ... More >> Service de Médecine Interne, Endocrinologie et Nutrition - CHU de Strasbourg Recruiting Strasbourg, Alsace, France, 67000 Contact: Bernard GOICHOT, Professor    +33 3 88 12 75 93    Bernard.Goichot@chru-strasbourg.fr    Service Endocrinologie, Diabétologie, maladies métaboliques - CHU de Bordeaux Recruiting Pessac, Aquitaine, France, 33600 Contact: Antoine TABARIN, Professor    +33 5 57 65 64 33    antoine.tabarin@chu-bordeaux.fr    Contact: Sarah CAZENAVE    +33 5 57 65 62 77    sarah.cazenave@chu-bordeaux.fr    Service d'Endocrinologie - Niveau 18 - Caen CHU Côte de Nacre Recruiting Caen, Basse-Normandie, France, 14000 Contact: Yves REZNIK, Professor    +33 2 31 06 45 86    reznik-y@chu-caen.fr    Service d'Endocrinologie -Diabète-Nutrition - CHU de REIMS Not yet recruiting Reims, Champagne-Ardenne, France, 51000 Contact: Brigitte DELEMER, Doctor    +33 3 26 78 81 01    bdelemer@chu-reims.fr    Service d'Endocrinologie, Diabétologie, Nutrition - CHU d'Amiens Not yet recruiting Amiens, Haut De France, France, 80000 Contact: Rachel DESAILLOUD, Pr    03.22.45.58.97 ext +33    Desailloud.Rachel@chu-amiens.fr    Endocrinologie, Diabète et Maladies Métaboliques - CHU de Rouen Not yet recruiting Rouen, Haute-Normandie, France, 76000 Contact: Hervé LEFEBVRE, Professor    +33 2 32 88 90 81    Herve.Lefebvre@chu-rouen.fr    Service d'Endocrinologie et des Maladies de la Reproduction- Assistance Publique - Hôpitaux de Paris - Hôpial Bicêtre Recruiting Le Kremlin Bicêtre, ILE DE France, France, 94275 Contact: Jacques YOUNG       jacques.young@bct.ap-hop-paris.fr    Assistance Publique - Hôpitaux de Paris - Hôpital COCHIN Recruiting Paris, ILE DE France, France, 75014 Contact: Jérôme BERTHERAT, Professor    +33 1 58 41 18 95    jerome.bertherat@ch.aphp.fr    Service d'Endocrinologie et Gynécologie - Assistance Publique - Hôpitaux de Paris - Pitié-Salpêtrière Withdrawn Paris, ILE DE France, France, 75651 Service d'Hypertension et de Médecine Vasculaire - Assistance Publique - Hôpitaux de Paris - Hôpital européen Georges Pompidou Recruiting Paris, ILE DE France, France, 75908 Contact: Pierre-François PLOUIN, Professor    +33 1 56 09 37 71    pierre-francois.plouin@egp.aphp.fr    Service d'Endocrinologie - Saint-Antoine - AP-HP Not yet recruiting Paris, Ile De France, France Contact: Sophie CHRISTIN-MAITRE, Pr    01.49.28.24.10 ext +33    sophie.christin-maitre@aphp.fr    Service d'Endocrinologie - CHU de Nancy Withdrawn Nancy, Lorraine, France, 54000 Service d'Endocrinologie et Maladies Métabolique - CHU de Toulouse Recruiting Toulouse, Midi-Pyrénées, France, 31000 Contact: Philippe CARON, Professor    +33 5 67 77 17 01    caron.p@chu-toulouse.fr    Service d'Endocrinologie, Diabétologie et Métabolisme - CHRU de LILLE Recruiting Lille, Nord-Pas-de-Calais, France, 59000 Contact: Marie-Christine VANTYGHEM, Professor    +33 3 20 44 45 35    mc-vantyghem@chru-lille.fr    Département Endocrinologie-Diabétologie -Nutrition - CHU d'ANGERS Recruiting Angers, Pays De La Loire, France, 49000 Contact: Sandrine LABOUREAU-SOARES, Doctor    +33 2 41 35 45 93    sasoares@chu-angers.fr    CIC Endocrinologie-Nutrition - CHU de Nantes Recruiting Nantes, Pays De La Loire, France, 44000 Contact: Bertrand CARIOU, Professor    +33 2 53 48 27 07    bertrand.cariou@univ-nantes.fr    Service d'Endocrinologie, Diabète et Maladies Métaboliques - Assistance publique - Hôpitaux de Marseille Recruiting Marseille, Provence-Alpes-Côte d'Azur, France, 13000 Contact: Thierry BRUE, Professor    +33 4 91 38 65 97    Thierry.BRUE@ap-hm.fr    Service Endocrinologie - CHU de Saint-Etienne Withdrawn Saint-Etienne, Rhône-Alpes, France, 42000 CHU de Poiriers Not yet recruiting Poitiers, France, 86021 Contact: Mathilde FRATY, Dr       mathilde.fraty@chu-poitiers.fr    Germany Endokrinologie, Diabetes und Ernährungsmedizin, Campus Mitte, Medizinische Klinik - Charité - Universitätsmedizin Berlin Not yet recruiting Berlin, Germany, 10117 Contact: Tina Kienitz       tina.kienitz@charite.de    Medizinische Klinik und Poliklinik IV, Endocrine Research Unit - Ludwig-Maximilians-Universität Not yet recruiting München, Germany, 80336 Contact: Felix Beuschlein       Felix.Beuschlein@med.uni-muenchen.de    Department of Internal Medicine I, Endocrine and Diabetes Uni -University Hospital Würzburg Recruiting Würzburg, Germany, 97080 Contact: Martin FAßNACHT, Pr       Fassnacht_M@ukw.de    Italy Clinica di Endocrinologia e Malattie del Metabolismo, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona Not yet recruiting Ancona, Italy Contact: Giorgio Arnaldi       Giorgio.Arnaldi@ospedaliriuniti.marche.it    S Orsola-Malpighi Hospital Recruiting Bologna, Italy, 40138 Contact: Uberto Pagotto       uberto.pagotto@unibo.it    University-Hospital of Padova Not yet recruiting Padova, Italy, 35128 Contact: Carla Scaroni       carla.scaroni@unipd.it    "Casa Sollievo della Sofferenza" Hospital Not yet recruiting San Giovanni Rotondo, Italy, 71013 Contact: Alfredo Scillitani       endocrino@operapadrepio.it    Dipartimento di Scienze Cliniche e Biologiche, Università degli Studi di Torino Not yet recruiting Torino, Italy, 10043 Contact: Massimo Terzolo       massimo.terzolo@unito.it Less <<
NCT00691314 Stroke Transi... More >>ent Ischemic Attack Atherosclerosis Stenosis Stents Less << Not Applicable Completed - China, Beijing ... More >> Beijing Tiantan Hospital Beijing, Beijing, China, 100050 Xuanwu Hospital Capital Medical University Beijing, Beijing, China, 100053 Peking Union Medical College Hospital Beijing, Beijing, China, 100730 China, Chongqing Southwest Hospital Chongqing, Chongqing, China, 400038 Daping Hospital Chongqing, Chongqing, China, 400042 China, Jiangsu Nanjing General Hospital of Nanjing Military Command Nanjing, Jiangsu, China, 210002 China, Jilin Jilin University Changchun, Jilin, China, 130021 China, Shanghai Huashan Hospital Fudan University Shanghai, Shanghai, China, 200040 China, Sichuan West China Center of Medical Sciences Chengdu, Sichuan, China, 610041 China, Tianjin The General Hospital Under Tianjin Medical Sciences University Tianjin, Tianjin, China, 300052 Less <<
NCT00421863 Hypertension Phase 4 Completed - Italy ... More >> Ospedale N. Melli San Pietro Vernotico, Brindisi, Italy, 72027 Ospedale Civile Mellini Chiari, BS, Italy, 25032 Ospedale Civile G. Chidichimo Trebisacce, Cosenza, Italy, 87075 Istituto Neuromed Pozzilli, Isernia, Italy, 86077 Presidio Ospedaliero F. Ferrari Casarano, Lecce, Italy, 73042 Nuovo Ospedale Versilia Lido di Camaiore, Lucca, Italy, 55043 Ospedale Civile Castiglione del Lago, Perugia, Italy, 06061 Ospedale Civile Beato Giacomo Villa Città della Pieve, Perugia, Italy, 06062 Presidio Ospedaliero Città di Castello Città di Castello, Perugia, Italy, 06012 Ospedale Civile Gubbio, Perugia, Italy, 06024 Presidio Ospedaliero Todi, Perugia, Italy, 06059 Ospedale Silvestrini Perugia, PG, Italy Ospedale Civile Sacile, Pordenone, Italy, 33077 Ospedale Scillesi D'America Scilla, Reggio Calabria, Italy, 89058 Ospedale Civile Thiesi, Sassari, Italy, 07047 Presidio Ospedaliero Poggibonsi, Siena, Italy, 53034 Ospedale Civile S. Antonio Abate Erice, Trapani, Italy, 91016 Ospedale S. Antonio San Daniele del Friuli, Udine, Italy, 33038 Ospedale Generale Regionale Aosta, Italy, 11100 Azienda Ospedaliera G. Rummo Benevento, Italy, 82100 Spedali Civili Brescia, Italy, 25123 Azienda Ospedaliera G. Brotzu - S. Michele Cagliari, Italy, 09134 Ospedale S. Elia Caltanissetta, Italy, 93100 Ospedale Garibaldi-Nesima Catania, Italy, 95122 Azienda Ospedaliera Mater Domini Catanzaro, Italy, 88100 Ospedale Clinicizzato Santissima Annunziata Chieti, Italy, 66013 Istituti Ospitalieri Cremona, Italy, 26100 Dimi - Disem Genova, Italy, 16132 Ospedale Generale Provinciale Gorizia, Italy, 34170 Policlinico Universitario Federico II Napoli, Italy, 80131 Azienda Ospedaliera di Perugia Perugia, Italy, 06132 Spedali Riuniti Pistoia, Italy, 51100 Ospedale Civile Ragusa, Italy, 97100 Ospedali Riuniti G. Melacrino F. Bianchi Reggio Calabria, Italy, 89124 Ospedale San Filippo Neri Roma, Italy, 00135 CTO Roma, Italy, 00145 Ospedlae San Camillo Roma, Italy, 00149 Ospedale San Camillo Roma, Italy, 00152 Ospedale San Giovanni Roma, Italy, 00184 Policlinico Universitario Sassari, Italy, 07100 Azienda Ospedaliera Siracusa, Italy, 96100 Azienda USL 4 Terni Terni, Italy, 05100 Ospedale San Vito Torino, Italy, 10134 Casa di Cura Villa Bianca Trento, Italy, 38100 Ospedale Belcolle Viterbo, Italy, 01100 Less <<
NCT03653845 Primary Aldosteronism ... More >> Hypertension Less << Phase 3 Recruiting January 1, 2020 China, Chongqing ... More >> The third hospital affiliated to the Third Military Medical University Recruiting Chongqing, Chongqing, China, 400042 Contact: Hongbo He, MD.    86-23-68757880    cqhehongbo@gmail.com    Principal Investigator: Zhiming Zhu, MD.          China The third hospital affiliated to the Third Military Medical University Recruiting Chongqing, China, 400042 Contact: Zhiming Zhu, MD, PhD    86-023-68705094    zhuzm@yahoo.com    Principal Investigator: Zhiming Zhu, MD, PhD Less <<
NCT03553810 Hypertensive Heart Disease Phase 3 Not yet recruiting December 31, 2021 Singapore ... More >> National Heart Centre Singapore Not yet recruiting Singapore, Singapore, 169609 Contact: Calvin WL Chin, MD, PhD          Principal Investigator: Calvin WL Chin, MD, PhD Less <<
NCT00684489 Hypertension Not Applicable Completed - -
NCT03255551 - Completed - -
NCT01658657 Hypertension ... More >>Plasma Renin Activity Less << Not Applicable Completed - United States, North Carolina ... More >> UNC Chapel Hill Chapel Hill, North Carolina, United States, 27599 Less <<
NCT01658657 - Completed - -
NCT00185120 Hypertension Phase 4 Completed - United States, Alabama ... More >> Mobile, Alabama, United States, 36693 United States, California Memorial Research Medical Center Long Beach, California, United States, 90806 National Research Institute Los Angeles, California, United States, 90057 Clinical Trials Research Roseville, California, United States, 95661 Apex Research Institute Santa Ana, California, United States, 92705 Orange County Research Center Tustin, California, United States, 92780 Westlake Medical Center Westlake Village, California, United States, 91361 United States, Florida Clinical Research of South Florida Coral Gables, Florida, United States, 33134 The Greater Fort Lauderdale Heart Group Research Fort lauderdale, Florida, United States, 33308 SFBC International Miami, Florida, United States, 33142 CLIRECO, Inc. Tamarac, Florida, United States, 33321 United States, Indiana Midwest Institute for Clinical Research Indianapolis, Indiana, United States, 46260 United States, Kansas Heartland Research Associates Wichita, Kansas, United States, 67207 United States, Maine Androscoggin Cardiology Research Auburn, Maine, United States, 04210 United States, North Carolina Internal Medicine Associates of Charlotte Charlotte, North Carolina, United States, 28211 Piedmont Medical Research Associates Winston-salem, North Carolina, United States, 27103 United States, Ohio The Lindner Clinical Trial Center Cincinnati, Ohio, United States, 45319 United States, Rhode Island Omega Medical Research Warwick, Rhode Island, United States, 02886 United States, Tennessee Volunteer Research Group, University of Tennessee Med. Ctr. Knoxville,, Tennessee, United States, 37920 United States, Texas Punzi Medical Center Carrollton, Texas, United States, 75006 Less <<
NCT02128386 - Unknown March 2016 Germany ... More >> Medical Outpatient Department of the Charité - Universitätsmedizin Berlin Recruiting Berlin, Germany, 10117 Less <<
NCT00664846 Stroke Not Applicable Completed - -
NCT02832973 Hypertension Resistant to Conv... More >>entional Therapy Less << Phase 4 Recruiting March 2018 Brazil ... More >> Juan Carlos Yugar-Toledo Recruiting São José do Rio Preto, São Paulo, Brazil, 15090000 Contact: Juan C Yugar-Toledo, MD, PhD    +55-17-32271899    yugarjuan@uol.com.br    Contact: Elizabeth DE Cestario, MD    +55-17-997186562    cesatrio@cardiol.br Less <<
NCT01353274 - Completed - -
NCT02087007 Vasospastic Angina Phase 3 Completed - Korea, Republic of ... More >> Yangsan Busan University Hospital Busan, Korea, Republic of, 626-770 Less <<
NCT03017950 Hypertension ... More >>Hyperlipidemias Less << Phase 1 Completed - Korea, Republic of ... More >> Inha University Hospital Incheon, Korea, Republic of Less <<
NCT00382421 Myocardial Ischemia Not Applicable Completed - Switzerland ... More >> Department of Cardiology, Hospital Lucerne Lucerne, Switzerland, 6000 Less <<
NCT01180413 Essential Hypertension ... More >> High Blood Pressure Less << Phase 4 Completed - Denmark ... More >> Aarhus University Hospital - dept. cardiology (A) Aarhus, Denmark, 8000 Less <<
NCT02913664 Cognitively Normal Older Adult... More >>s Hypertension Subjective Cognitive Decline Family History of Alzheimer's Disease Less << Phase 2 Phase 3 Recruiting September 2022 United States, Kansas ... More >> University of Kansas Medical Center Research Institute Recruiting Kansas City, Kansas, United States, 66160 Contact: Angela VanSciver    913-945-5029    avansciver@kumc.edu    Principal Investigator: Jeffrey Burns, MD          United States, Louisiana Pennington Biomedical Research Center Recruiting Baton Rouge, Louisiana, United States, 70808 Contact: Sara Goff    225-763-0910    sara.goff@pbrc.edu    Principal Investigator: Jeffrey Keller, PhD          United States, Missouri Washington University in St. Louis Recruiting Saint Louis, Missouri, United States, 63110 Contact: Monica Sewell    314-286-2716    sewellm@wustl.edu    Principal Investigator: Ellen Binder, MD          United States, Texas UT Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 Contact: Lauren Braunfeld, BS    214-345-7134    LaurenBraunfeld@texashealth.org    Contact: Ann Jacob, BSN    214-345-4665    AnnJacob@TexasHealth.org    Principal Investigator: Rong Zhang, PhD Less <<
NCT00144144 Hypertension ... More >>Diabetes Mellitus, Type 2 Less << Phase 4 Unknown - Japan ... More >> Dept. of Clinical Immunology, Clinical Bioinformatics Research Unit, Graduate School of Medicine, the University of Tokyo Hongo, Bunkyo-ku, Tokyo, Japan, 113-8655 Less <<
NCT02130687 Type 2 Diabetes Mellitus ... More >> Hypertension Less << Not Applicable Recruiting June 2020 United States, Tennessee ... More >> Vanderbilt University Recruiting Nashville, Tennessee, United States, 37232 Contact: Jessica R Wilson, M.D.       jessica.r.wilson@vanderbilt.edu    Contact: Scott Hubers, M.D.       scott.hubers@vanderbilt.edu    Principal Investigator: Nancy J Brown, M.D.          Sub-Investigator: Jessica Devin, M.D.          Sub-Investigator: Jessica R Wilson, M.D.          Sub-Investigator: Claudia E Ramirez, M.D.          Sub-Investigator: Scott Hubers, M.D. Less <<
NCT01353274 - Completed - -
NCT02966717 Renal Insufficiency, Chronic ... More >> Nephrotic Syndrome Less << Phase 2 Active, not recruiting October 2021 China, Guangdong ... More >> Zhujiang Hospital, Southern Medical University Guangzhou, Guangdong, China, 510282 Less <<
NCT03015311 Primary Hypertension Not Applicable Active, not recruiting December 2021 -
NCT03276598 Hypertension ... More >>Pharmacogenetics Less << Phase 4 Completed - Finland ... More >> Helsinki University Central Hospital Helsinki, Finland Less <<
NCT00438113 Atrial Fibrillation Phase 4 Completed - Canada, Nova Scotia ... More >> QE II Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 3A7 Less <<
NCT00661895 - Completed - -
NCT02893358 Masked Hypertension Phase 4 Unknown - China, Shanghai ... More >> Ruijin Hospital Not yet recruiting Shanghai, Shanghai, China, 200025 Contact: Yan Li, Professor    021-64370045 ext 663228    liyanshcn@yahoo.com    Principal Investigator: Yan Li, Professor Less <<
NCT02058472 Healthy Adult Volunteers Phase 1 Unknown May 2014 -
NCT01499511 - Unknown March 2014 United Kingdom ... More >> International Centre for Circulatory Health Not yet recruiting London, United Kingdom, W2 1LA Contact: Judith A Mackay, MBBS PhD MRCP    +442075941395    judith.mackay@imperial.nhs.uk    Contact: Peter S Sever, MBCHB PhD FRCP    +442075941099    p.sever@imperial.ac.uk    Principal Investigator: Judith A Mackay, MBBS PhD MRCP Less <<
NCT00902304 - Completed - -
NCT00902304 Hypertension Phase 4 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Australia Professor Garry Jennings-Co Principal Investigator Melbourne, Australia Professor Simon Stewart-Principal Investigator Melbourne, Australia Less <<
NCT02774460 Hypertension Phase 4 Not yet recruiting November 2020 Sweden ... More >> Uppsala University hospital, Internal medicine research, Oscar II Not yet recruiting Uppsala, Sweden, SE-752 37 Contact: Kerstin Marttala, Study nurse    004618-6113632    kerstin.marttala@akademiska.se    Principal Investigator: Johan Sundstrom, Professor Less <<
NCT00142584 Hypertension Phase 3 Completed - United States, West Virginia ... More >> Mylan Pharmaceuticals Inc. Morgantown, West Virginia, United States, 26505 Less <<
NCT01643434 Hypertension Phase 4 Unknown July 2014 Brazil ... More >> University of São Paulo General Hospital Recruiting São Paulo, Brazil, 05403-000 Contact: Eduardo M. krieger, Doctor    +55113069-5048    edkrieger@incor.usp.br    Contact: Jose E. krieger, Doctor    +55113069 5068    zecakrieger@gmail.com    Principal Investigator: Eduardo M. Krieger, Doctor Less <<
NCT02034435 Metabolic Syndrome Not Applicable Recruiting December 2018 United States, Tennessee ... More >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232-6602 Contact: Loretta Byrne, RN    615-322-2105    loretta.byrne@vanderbilt.edu    Contact: Holly Waldrop       holly.waldrop@vanderbilt.edu    Principal Investigator: James M Luther, MD Less <<
NCT02148991 - Completed - Greece ... More >> Georgios Gennimatas General State Hospital Athens, Holargos, Greece, 11527 Georgios Gennimatas General State Hospital Athens, Greece, 10682 Less <<
NCT00760266 - Completed - -
NCT02232880 Hypertension Phase 2 Terminated(failure to recruit) - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232-6602 Less <<
NCT00760266 Hypertension Phase 4 Completed - United States, New Jersey ... More >> Sites in USA East Hanover, New Jersey, United States, 07936 Less <<
NCT01190007 Hypertension ... More >>Hypercholesterolemia Angina Pectoris Less << Phase 4 Completed - Japan ... More >> Healthcare Corporation MEDOC Medical Dock&Clinic Nagoya, Aichi, Japan Beppu Medical Clinic Dazaifu, Fukuoka, Japan Morizono medical clinic Kitakyushu, Fukuoka, Japan Gakkentoshi Clinic Nishi-ku, Fukuoka, Japan Department of internal gastro-intestinal medicine Ohshima clinic Sapporo, Hokkaido, Japan Oofuji Clinic Amagasaki, Hyogo, Japan Mizutani Clinic Kobe, Hyogo, Japan Nada Clinic Kobe, Hyogo, Japan Idaimae-naika Clinic Kawasaki, Kanagawa, Japan Sakakibara Clinic, Wakaumekai Medical Corporation Yokohama, Kanagawa, Japan Masunaga Clinic Fujimi, Saitama, Japan Sugiura Clinic Kawaguchi, Saitama, Japan Masuda Clinic Adachi-ku, Tokyo, Japan Wakasugi Family Clinic Arakawa-ku, Tokyo, Japan Medical Care Law Person Corporation Kenseikai, Kobayashi Internal Medicine Clinic Koto-ku, Tokyo, Japan Banno Clinic Ohta-ku, Tokyo, Japan Hatano Medical Clinic Setagaya-ku, Tokyo, Japan Suzuki Circulatory Medical Clinic Setagaya-ku, Tokyo, Japan Yano Cardiovascular Clinic Fukuoka, Japan Nakaoka Clinic Osaka, Japan Less <<
NCT03021265 - Active, not recruiting April 30, 2019 Japan ... More >> Nippon Boehringer Ingelheim Co., Ltd Tokyo, Japan, 4570047 Less <<
NCT02232880 - Terminated(failure to recruit) - -
NCT01190007 - Completed - -
NCT03659149 Hypertension ... More >>Dyslipidemias Less << Phase 1 Completed - Korea, Republic of ... More >> Seoul Saint Mary's Hospital Seoul, Korea, Republic of Less <<
NCT01870739 Hypertension Phase 2 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Erlangen, Germany, 91054 Switzerland Novartis Investigative Site Basel, Switzerland, 4031 United Kingdom Novartis Investigative Site Glasgow, Scotland, United Kingdom, G12 8TA Less <<
NCT01870739 - Completed - -
NCT02496910 Hypertension Phase 1 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Chunju, Korea, Republic of, 561-712 Less <<
NCT02449811 - Recruiting February 2018 Switzerland ... More >> University Hospital Recruiting Basel, Switzerland, 4031 Principal Investigator: Manuel Haschke, MD Less <<
NCT02412761 Essential Hypertension Not Applicable Completed - United States, Texas ... More >> University of Texas at Houston Medical School; Pediatric Nephrology and Hypertension Clinics Houston, Texas, United States, 77030 Less <<
NCT03578042 Hypertension Phase 4 Recruiting December 30, 2019 Lebanon ... More >> Hotel Dieu de France Hospital Recruiting Beirut, Lebanon, Beirut Contact: Rabih R Azar, MD, MPH    +9611615300 ext 9408    razar@usj.edu.lb Less <<
NCT02433119 Hypertension Phase 4 Completed - Korea, Republic of ... More >> Gachon University Gil Hospital Incheon, Korea, Republic of Less <<
NCT02412761 - Completed - -
NCT01256411 Essential Hypertension Phase 2 Completed - China, Chongqing ... More >> Novartis Investigative Site Chongqing, Chongqing, China, 400042 China, Hebei Novartis Investigative Site Shijiazhuang, Hebei, China, 050000 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310006 China Novartis Investigative Site Beijing, China, 100044 Novartis Investigative Site Beijing, China, 100730 Novartis Investigative Site Tianjin, China, 300142 Japan Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 231-0023 Novartis Investigative Site Shimotsuke-city, Tochigi, Japan, 329-0498 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-0031 Novartis Investigative Site Chiyoda-ku, Tokyo, Japan, 100-0005 Novartis Investigative Site Kiyose-city, Tokyo, Japan, 204-0021 Novartis Investigative Site Kunitachi, Tokyo, Japan, 186-0001 Novartis Investigative Site Minato-ku, Tokyo, Japan, 105-7390 Novartis Investigative Site Minato-ku, Tokyo, Japan, 108-0075 Novartis Investigative Site Ota-ku, Tokyo, Japan, 143-0023 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 141-0032 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 142-0053 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 142-0063 Novartis Investigative Site Toshima-ku, Tokyo, Japan, 171-0021 Korea, Republic of Novartis Investigative Site Bucheon, Gyeonggi-do, Korea, Republic of, 424-717 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 137-701 Novartis Investigative Site Koyang, Kyunggi, Korea, Republic of, 410-719 Novartis Investigative Site Daegu, Korea, Republic of, 705-703 Novartis Investigative Site Seoul, Korea, Republic of, 150-950 Novartis Investigative Site Seoul, Korea, Republic of, 152-703 Taiwan Novartis Investigative Site Changhua, Taiwan, 500 Novartis Investigative Site Taichung, Taiwan, 40447 Novartis Investigative Site Taipei, Taiwan, 10002 Novartis Investigative Site Taipei, Taiwan, 10449 Novartis Investigative Site Taipei, Taiwan, 114 Thailand Novartis Investigative Site Bangkok, Thailand, 10400 Novartis Investigative Site Bangkok, Thailand, 10700 Novartis Investigative Site Chiang Mai, Thailand, 50200 Less <<
NCT01256411 - Completed - -
NCT02377661 Hypertension Phase 4 Completed - Austria ... More >> GP practices Vienna, Austria Less <<
NCT00039975 HIV Infections ... More >> Cardiovascular Diseases Hypertension Less << Phase 1 Completed - United States, California ... More >> Univ of California San Francisco San Francisco, California, United States, 94110 Stanford Univ Med Ctr Stanford, California, United States, 943055107 United States, Colorado Univ of Colorado Health Sciences Ctr Denver, Colorado, United States, 80262 United States, Maryland Johns Hopkins Hosp Baltimore, Maryland, United States, 21287 United States, Minnesota Univ of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Washington Univ (St. Louis) St. Louis, Missouri, United States, 63108 United States, New York Cornell Univ Med Ctr New York, New York, United States, 10021 Univ of Rochester Medical Center Rochester, New York, United States, 14642 United States, Ohio Univ of Cincinnati Cincinnati, Ohio, United States, 452670405 Less <<
NCT00134160 Hypertension ... More >>Cardiovascular Diseases Less << Phase 4 Completed - Japan ... More >> Department of Cardiovascular Medicine Graduate School of Medical Science Kumamoto University 1-1-1 Honjyo, Kumamoto-City, Kumamoto, Japan, 860-8556 OSCAR-Study Data Center ShinjukuParkTower30FN, 3-7-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, Japan, 163-1030 Less <<
NCT00637078 Hypertension ... More >>Hypercholesterolemia Less << Phase 4 Completed - Canada, Ontario ... More >> Robarts Research Insititute London, Ontario, Canada, N6A 5K8 Less <<
NCT02387554 Hypertension(HTN) Phase 1 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Bundang, Gyeonggi, Korea, Republic of Less <<
NCT02387554 - Completed - -
NCT02900729 Hypertension Phase 3 Unknown February 2018 China, Hunan ... More >> The Third Xiangya Hospital of Central South University Not yet recruiting Changsha, Hunan, China Contact: Zhihui Zhang, Dr.       zhangzhihui0869@126.com    Contact: Xiaoyan Wang, Dr.          China, Shanghai Zhongshan Hospital affiliated to Fu Dan University Not yet recruiting Shanghai, Shanghai, China, 200032 Contact: Junbo Ge, Dr.       ge.junbo@zs-hospital.sh.cn    Contact: Li Shen, Dr.       shen.li@zs-hospital.sh.cn    Changhai Hospital affiliated to Second Military Medical University Not yet recruiting Shanghai, Shanghai, China Contact: Xianxian Zhao, Dr.       13601713431@163.com    Contact: Zhifu Guo, Dr.          Putuo Hospital affiliated to Shanghai Traditional Chinese Medicine University Not yet recruiting Shanghai, Shanghai, China Contact: Zongjun Liu, Dr.       lzj72@126.com    Contact: Jia Shi, Dr.          Shanghai Chest Hospital affiliated to Shanghai Jiao Tong University Not yet recruiting Shanghai, Shanghai, China Contact: Weiyi Fang, Dr.       fwychest@163.com    Contact: Shaofeng Guan, Dr.       gsf@qq.com    Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University Not yet recruiting Shanghai, Shanghai, China Contact: Changqian Wang, Dr.       wcqian@hotmail.com    Contact: Zhaofang Yin, Dr.       13072103901@163.com    Shanghai Sixth People's Hospital affiliated to Shanghai Jiao Tong University Not yet recruiting Shanghai, Shanghai, China Contact: Jingbo Li, Dr.       jbli@medmail.com.cn    Contact: Yesheng Pan, Dr.       panyesheng@163.com    Tongji Hospital affiliated to Tongji University Not yet recruiting Shanghai, Shanghai, China Contact: Xuebo Liu, Dr.       lxb70@hotmail.com    Contact: Yang Liu, Dr.       961165@sina.com    Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine Chongming Branch Not yet recruiting Shanghai, Shanghai, China Contact: Yingmin Lu, Dr.       lymkk@sohu.com    Contact: Shuxin Hou, Dr.       1461396934@qq.com    China, Zhejiang Sir Run Run Shaw Hospital affiliated to Zhejiang University Not yet recruiting Hangzhou, Zhejiang, China Contact: Guosheng Fu, Dr.       fugs@medmail.com.cn    Contact: Chenyang Jiang, Dr.          The Second Hospital affiliated to Zhejiang University Not yet recruiting Hangzhou, Zhejiang, China Contact: Jianan Wang, Dr.       wang_jian_an@tom.com    Contact: Jun Jiang, Dr.       drjayj@Hotmail.com    Taizhou Hospital Not yet recruiting Taizhou, Zhejiang, China Contact: Jianjun Jiang, Dr.       taizhoujiangjj@163.com    Contact: Yafei Mi, Dr.          The First Hospital affiliated to Wenzhou Medical College Not yet recruiting Wenzhou, Zhejiang, China Contact: Weijian Huang, Dr.       weijianhuang69@yahoo.com.cn    Contact: Zhouqing Huang, Dr.       susiehzq@126.com Less <<
NCT00237588 Hypertension Phase 4 Completed - Norway ... More >> Cardiovascular and Renal Research Center/ Department of Cardiology, Ullevaal University Hospital Oslo, Norway, 0407 Less <<
NCT03354143 Hypertension Phase 2 Recruiting October 31, 2022 United States, Texas ... More >> UT Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 Principal Investigator: Rong Zhang, Ph.D.          Principal Investigator: Wanpen Vongpatanasin, MD Less <<
NCT02847338 Hypertension Phase 4 Recruiting November 2021 United Kingdom ... More >> Cambridge University Hospitals NHS Foundation Trust Recruiting Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Contact: Ella James    01223 349762       Principal Investigator: Joseph Cheriyan          Queen Elizabeth Hospital Recruiting Birmingham, United Kingdom, B15 2TH Principal Investigator: Una Martin          Sandwell & West Birmingham Hospitals NHS Trust Recruiting Birmingham, United Kingdom, B18 7QH Contact: Ronnie HAYNES    0121 507 5113    ronnie.haynes@nhs.net    Contact: Rebecca Brown    0121 507 6657    Rebecca.brown15@nhs.net    Principal Investigator: Gregory Lip          University Hospital Llandough Recruiting Cardiff, United Kingdom, CF64 2XX Contact: Maggie Munnery    029 20416278    MMunnery@cardiffmet.ac.uk    Contact: Barry McDonnell    029 206827    bmcdonnell@cardiffmet.ac.uk    Principal Investigator: James Coulson          University of Glasgow Recruiting Glasgow, United Kingdom, G12 8TA Principal Investigator: Sandosh Padmanabhan          Leicester General Hospital Not yet recruiting Leicester, United Kingdom, LE5 4PW Principal Investigator: Kamlesh Khunti          William Harvey Research Institute, Barts and the London Medical School Recruiting London, United Kingdom, EC1M 6BQ Principal Investigator: David Collier          St. Thomas Hospital Recruiting London, United Kingdom, SE1 7EH Principal Investigator: Phil Chowienczyk          Sub-Investigator: Luca Faconti          Imperial College Healthcare NHS Trust St. Marys Hospital Not yet recruiting London, United Kingdom, W2 1NY Principal Investigator: Simon Thom          University College London Not yet recruiting London, United Kingdom, WC1E 7HB Principal Investigator: Alun Hughes          Manchester Royal Infirmary Recruiting Manchester, United Kingdom, M13 9WL Principal Investigator: Tony Heagerty          Newcastle Hospital NHS Foundation Trust Not yet recruiting Newcastle, United Kingdom, NE2 4HH Principal Investigator: Simon Thomas Less <<
NCT01823913 Healthy Phase 1 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT00834600 Hypertension Not Applicable Completed - United States, New York ... More >> Lincoln Medical and Mental Health Center Bronx, New York, United States, 10451 Albert Einstein College of Medicine - GCRC Bronx, New York, United States, 10461 Jacobi Medical Center Bronx, New York, United States, 10461 Bronx Nephrology Hypertension, PC Bronx, New York, United States, 10467 Ralph Yung, MD Bronx, New York, United States, 10467 Less <<
NCT02166398 Healthy Phase 1 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Jongno-gu, Korea, Republic of, 110-744 Less <<
NCT01264692 Essential Hypertension Phase 2 Completed - Israel ... More >> Clinical Investigative Site 4000 Afula, Israel, 18101 Clinical Investigative Site 1003 Ashkelon, Israel, 78278 Clinical Investigative Site 1008 Beer Sheva, Israel, 84101 Clinical Investigative Site 1004 Givatayim, Israel, 53583 Clinical Investigative Site 1009 Holon, Israel, 58100 Clinical Investigative Site 1000 Jerusalem, Israel, 91004 Clinical Investigative Site 1006 Nazareth, Israel, 16100 Clinical Investigative Site 1007 Nazareth, Israel, 16100 Clinical Investigative Site 1005 Safed, Israel, 13100 Clinical Investigative Site 1010 Tel Aviv, Israel, 66872 Clinical Investigative Site 1012 Tel-Hashomer, Israel, 52621 Serbia Clinical Investigative Site 3001 Belgrade, Serbia, 11000 Clinical InvestigativeSite 3003 Belgrade, Serbia, 11000 Clinical Investigative Site 4001 Belgrade, Serbia, 11040 Clinical Investigative Site 3004 Belgrade, Serbia, 11080 Clinical Investigative Site 3000 Niska Banja, Serbia, 18205 Clinical Investigative Site 4002 Pancevo, Serbia, 26000 Clinical Investigative Site 3002 Zemun, Serbia, 11080 Less <<
NCT01776047 Healthy Male Volunteer Phase 1 Completed - -
NCT00368277 - Completed - -
NCT03666351 Aortic Stenosis ... More >> Aortic Regurgitation Hypertension LVM Left Ventricular Hypertrophy Less << Phase 4 Recruiting January 31, 2022 Korea, Republic of ... More >> 10 Institutions Including Asan Medical Center Recruiting Seoul, Korea, Republic of Contact: kang Less <<
NCT01091753 Hypertension Phase 4 Completed - Korea, Republic of ... More >> Severance Hospital, Yonsei University College of Medicine Seoul, Korea, Republic of Less <<
NCT02742467 Hypertension Phase 4 Completed - Nigeria ... More >> University of Abuja Teaching Hospital Abuja, Federal Capital Territory, Nigeria, 90001 Less <<
NCT01365481 - Completed - -
NCT00368277 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT01198496 Hypertension ... More >>Stroke Blood Pressure Less << Phase 4 Recruiting December 2019 Japan ... More >> Jichi Medical Univercity Recruiting Shimotsuke, Tochigi, Japan, 329-0498 Contact: Kazuyuki Shimada, MD       kazuyuki@jichi.ac.jp    Principal Investigator: Kazuomi Kario, MD Less <<
NCT02699645 Acute Intracerebral Haemorrhag... More >>e (ICH) Hypertension Less << Phase 3 Recruiting December 2023 -
NCT03682692 Hypertension Phase 4 Recruiting December 2019 China ... More >> Shanghai Institite of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine Recruiting Shanghai, China, 200025 Contact: Jiguang Wang, MD, PhD    86-21-64370045 ext 610911    jiguang_wang_jgw@yahoo.com Less <<
NCT01255475 Heart Failure ... More >> Cardiac Failure Congestive Heart Failure Less << Phase 2 Phase 3 Completed - Brazil ... More >> Heart Institute (InCor) do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo São Paulo, SP, Brazil, 05403000 Less <<
NCT01365481 Hypertension ... More >>Chronic Kidney Disease Less << Phase 3 Completed - Colombia ... More >> Novartis Investigative Site Bucaramanga, Santander, Colombia, 0001 Novartis Investigative Site Barranquilla, Colombia Novartis Investigative Site Cali, Colombia Finland Novartis Investigative Site Helsinki, Finland, 00029 Germany Novartis Investigative Site Bochum, Germany, 44791 Novartis Investigative Site Cottbus, Germany, 03048 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Homburg, Germany, 66421 Novartis Investigative Site Rostock, Germany, 18107 Guatemala Novartis Investigative Site Guatemala City, Guatemala, 01010 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 03080 Philippines Novartis Investigative Site Manila, Philippines, 1000 Novartis Investigative Site Quezon City, Philippines, 1100 Novartis Investigative Site Quezon City, Philippines, 1101 Poland Novartis Investigative Site Warszawa, Poland, 04-154 Romania Novartis Investigative Site Cluj-Napoca, Jud Cluj, Romania Novartis Investigative Site Tg. Mures, jud Mures, Romania, 540104 Novartis Investigative Site Timisoara, jud. Timis, Romania, 300011 Novartis Investigative Site Bucuresti, Romania, 041451 Novartis Investigative Site Bucuresti, Romania, 20395 Novartis Investigative Site Iasi, Romania, 700309 Russian Federation Novartis Investigative Site Kazan, Russian Federation, 420012 Novartis Investigative Site Moscow, Russian Federation, 119991 Novartis Investigative Site Moscow, Russian Federation, 125315 Novartis Investigative Site Moscow, Russian Federation, 127412 Novartis Investigative Site Voronezh, Russian Federation, 394036 Singapore Novartis Investigative Site Singapore, Singapore, 119074 Novartis Investigative Site Singapore, Singapore, 229899 Less <<
NCT00006294 - Completed - United States, Kentucky ... More >> University of Kentucky Lexington, Kentucky, United States, 40536 Less <<
NCT02278471 Hypertension ... More >>Hyperlipidemia Less << Phase 2 Completed - United States, Alabama ... More >> Franklin Primary Health Center Mobile, Alabama, United States, 36603 Less <<
NCT02814500 Healthy Phase 1 Unknown September 2016 -
NCT00772499 Hypertension Phase 4 Completed - United States, North Carolina ... More >> Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States, 27157 Less <<
NCT00454662 Hypertension ... More >>Cardiovascular Disease Diabetes Less << Phase 4 Completed - Japan ... More >> COLM-Study Data Center Kamiyacho MT Bld.14F, 4-3-20 Toranomon Minato-ku, Tokyo, Japan, 105-0001 Less <<
NCT00234871 Hypertension ... More >>Diabetes Proteinuria Less << Phase 4 Completed - -
NCT01252238 Insulin Sensitivity ... More >> Aortic Compliance Diastolic Function Less << Not Applicable Terminated(Study sponsor termi... More >>nated study due to AE's reported with valsartan and aliskiren) Less << - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00160212 Hypertension Phase 2 Completed - -
NCT02817503 Hypertension ... More >>Hyperhomocysteinemia Less << Phase 4 Unknown December 2016 China, Shandong ... More >> the People's Hospital of Rongcheng Rongcheng, Shandong, China, 264300 Less <<
NCT01252238 - Terminated(Study sponsor termi... More >>nated study due to AE's reported with valsartan and aliskiren) Less << - -
NCT00659451 Essential Hypertension ... More >> Diabetes Mellitus Less << Phase 3 Unknown April 2009 Italy ... More >> University of Pavia Recruiting Pavia, Italy Contact: Paola Preti, MD    +39 0382 526217       Sub-Investigator: Paola Preti Less <<
NCT01713920 Hypertension Phase 4 Completed - Korea, Republic of ... More >> The Catholic University of Korea Bucheon St. Mary's Hospital Bucheon, Korea, Republic of The Catholic University of Korea Seoul St. Mary's Hospital Seoul, Korea, Republic of Less <<
NCT00264212 Hypertension Phase 4 Completed - Chile ... More >> Sanofi-Aventis Santiago, Chile China Sanofi-Aventis Shangai, China Indonesia Sanofi-Aventis Jakarta, Indonesia Korea, Republic of Sanofi-Aventis Seoul, Korea, Republic of Mexico Sanofi-Aventis Mexico, Mexico Philippines Sanofi-Aventis Manila, Philippines Taiwan Sanofi-Aventis Taipei, Taiwan Thailand Sanofi-Aventis Bangkok, Thailand Less <<
NCT01176032 - Completed - -
NCT02277691 - Completed - -
NCT03757390 Healthy Subjects Phase 1 Recruiting December 14, 2018 Korea, Republic of ... More >> Korea University Anam Hospital Recruiting Seoul, Korea, Republic of Less <<
NCT03639493 Healthy Male Subjects Phase 1 Completed - Korea, Republic of ... More >> Korea University Anam Hospital Seoul, Korea, Republic of Less <<
NCT02277691 Essential Hypertension Phase 3 Completed - Japan ... More >> Nagoya-shi, Aichi, Japan Chiba-shi, Chiba, Japan Itojima-shi, Fukuoka, Japan Kouriyama-shi, Fukushima, Japan Sapporo-shi, Hokkaido, Japan Amagasaki-shi, Hyougo, Japan Tsukuba-shi, Ibaragi, Japan Morioka-shi, Iwate, Japan Sakaide-shi, Kagawa, Japan Takamatsu-shi, Kagawa, Japan Kawasaki-shi, Kanagawa, Japan Kyoto-shi, Kyoto, Japan Uji-shi, Kyoto, Japan Sendai-shi, Miyagi, Japan Hirakata-shi, Osaka, Japan Osaka-shi, Osaka, Japan Takatsuki-shi, Osaka, Japan Saitama-shi, Saitama, Japan Tokorozawa-shi, Saitama, Japan Yaizu-shi, Shizuoka, Japan Chiyoda-ku, Tokyo, Japan Choufu-shi, Tokyo, Japan Kodaira-shi, Tokyo, Japan Koutou-ku, Tokyo, Japan Setagaya-ku, Tokyo, Japan Shinagawa-ku, Tokyo, Japan Shinjuku-ku, Tokyo, Japan Choufu-shi, Japan Kawasaki-shi, Japan Koutou-ku, Japan Morioka-shi, Japan Sakaide-shi, Japan Setagaya-ku, Japan Shinagawa-ku, Japan Shinjuku-ku, Japan Tsukuba-shi, Japan Uji-shi, Japan Yaizu-shi, Japan Less <<
NCT00550953 Hypertension Phase 3 Completed - Japan ... More >> 1235.14.002 Boehringer Ingelheim Investigational Site Chofu, Tokyo, Japan 1235.14.003 Boehringer Ingelheim Investigational Site Musashino, Tokyo, Japan 1235.14.005 Boehringer Ingelheim Investigational Site Nishi-ku, Hiroshima, Hiroshima, Japan 1235.14.004 Boehringer Ingelheim Investigational Site Osaka, Osaka, Japan 1235.14.001 Boehringer Ingelheim Investigational Site Shinjuku-ku, Tokyo, Japan Less <<
NCT00765947 - Completed - -
NCT01176032 Hypertension ... More >>Left Ventricle Hypertrophy Less << Phase 4 Completed - Spain ... More >> Novartis Investigative Site Sanlúcar de Barrameda, Andalucia, Spain, 11540 Novartis Investigative Site Sevilla, Andalucia, Spain, 41009 Novartis Investigative Site Sevilla, Andalucia, Spain, 41013 Novartis Investigative Site Utrera, Andalucia, Spain, 41710 Novartis Investigative Site Burgos, Castilla y Leon, Spain, 09005 Novartis Investigative Site Barcelona, Cataluña, Spain, 08036 Novartis Investigative Site Girona, Cataluña, Spain, 17007 Novartis Investigative Site L'Hospitalet de Llobregat, Cataluña, Spain, 08907 Novartis Investigative Site Santa Coloma de Gramanet, Cataluña, Spain Novartis Investigative Site Alicante, Comunidad Valenciana, Spain, 03004 Novartis Investigative Site Torrevieja (Alicante), Comunidad Valenciana, Spain, 03186 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46010 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46014 Novartis Investigative Site Santiago de Compostela, Galicia, Spain, 15706 Novartis Investigative Site Galdakano, Pais Vasco, Spain, 48960 Novartis Investigative Site Bilbao, País Vasco, Spain, 48013 Novartis Investigative Site Vitoria, País Vasco, Spain Novartis Investigative Site Barcelona, Spain, 08006 Novartis Investigative Site Barcelona, Spain, 08025 Novartis Investigative Site Madrid, Spain, 28009 Novartis Investigative Site Madrid, Spain, 28035 Novartis Investigative Site Madrid, Spain, 28040 Novartis Investigative Site Madrid, Spain, 28041 Novartis Investigative Site Madrid, Spain, 28046 Novartis Investigative Site Santander, Spain, 39008 Less <<
NCT00550953 - Completed - -
NCT01500590 Diabetes Hype... More >>rtensive Disease Less << Phase 4 Active, not recruiting August 2019 China ... More >> Hospital Authority, HKEC, FM&PHC Hong Kong, China Less <<
NCT00765947 Essential Hypertension ( Mild ... More >>to Moderate) Less << Phase 4 Completed - France ... More >> Investigative Site Paris, France Hungary Investigative Site Budapest, Hungary Romania Investigative Site Bucharest, Romania Slovakia Investigative Site Bratislava, Slovakia Less <<
NCT00224549 Hypertension Phase 4 Completed - France ... More >> Investigation Clinical Center European Georges Pompidou Hospital Paris, Ile de France, France, 75015 Less <<
NCT00805311 Carotid Artery Stenosis ... More >> Atherosclerosis Stroke Less << Phase 4 Terminated(Due to the clear ad... More >>vantage of carotid endarterectomy) Less << - Russian Federation ... More >> Russian Cardiology Research and Production Center Moscow, Russian Federation, 121552 Russian Cardiology Research and Production Center Moscow, Russian Federation Less <<
NCT01259297 - Terminated(Terminated early in... More >> agreement with Health Authorities for feasibility reasons) Less << - -
NCT01259297 Cardiovascular Events Phase 3 Terminated(Terminated early in... More >> agreement with Health Authorities for feasibility reasons) Less << - -
NCT02504606 Hypertension Phase 1 Completed - -
NCT02089399 Healthy Phase 1 Completed - Korea, Republic of ... More >> Samsung medical center Seoul, Korea, Republic of Less <<
NCT01665235 Blood Pressure Variability ... More >> Intracranial Artery Stenosis Less << Not Applicable Unknown August 2014 China, Shanghai ... More >> RenJi Hospital Recruiting Shanghai, Shanghai, China, 200127 Principal Investigator: Guowen Shi, MD Less <<
NCT03210532 Hypertension ... More >>Dyslipidemia Less << Phase 3 Completed - Korea, Republic of ... More >> Sevrance Hospital Seoul, Korea, Republic of Less <<
NCT03264352 Diabetes Mellitus, Type 2 ... More >> Stroke Blood Pressure Prehypertension Cardiovascular Risk Factor Less << Phase 4 Not yet recruiting September 2022 China, Guangdong ... More >> Guangdong General Hospital Guangzhou, Guangdong, China, 501080 Less <<
NCT02834403 Metastatic Triple Negative Bre... More >>ast Cancer Less << Phase 1 Phase 2 Recruiting August 2019 United States, Texas ... More >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Houston Methodist Cancer Center    713-441-0629    ccresearch@houstonmethodist.org Less <<
NCT00579254 - Terminated(See the termination... More >> reason in detailed description.) Less << - -
NCT00579254 - Terminated(See the termination... More >> reason in detailed description.) Less << - -
NCT03195023 Renal Insufficiency, Chronic ... More >> Proteinuria Less << Phase 4 Recruiting June 2021 Spain ... More >> Gregorio Maranon Hospital Recruiting Madrid, Spain, 28007 Contact: Maria Angeles Goicoechea, PhD, MD    0034609838684    marian.goicoechea@gmail.com    Contact: Ana María García, MD    0034676611045    anamgarciaprieto@gmail.com Less <<
NCT02916602 Hypertension Phase 3 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Gyeonggi-Do, Korea, Republic of, 463-707 Less <<
NCT00439738 Hypertension Phase 4 Completed - United States, Alabama ... More >> Terence T. Hart, MD Muscle Shoals, Alabama, United States, 35662 United States, California Westlake Medical Research Westlake Village, California, United States, 91361 United States, Oklahoma Oklahoma Cardiovascular & Hypertension Oklahoma City, Oklahoma, United States, 73132 United States, Texas Northeast Tarrant Internal Medicine Assoc Euless, Texas, United States, 76040 United States, Washington Frandsen Family Medicine Port Orchard, Washington, United States, 98366 Less <<
NCT01518855 Hypertension Phase 4 Completed - Japan ... More >> Sapporo, Hokkaido, Japan, 060-0003 Setagaya-ku, Tokyo, Japan, 158-0097 Shinjuku-ku, Tokyo, Japan, 163-6003 Hiroshima, Japan, 733-0011 Less <<
NCT00140985 Renal Disorder Phase 4 Completed - -
NCT00669435 Hypertension Phase 4 Unknown April 2009 Italy ... More >> University of Pavia Recruiting Pavia, Italy Contact: Giuseppe Derosa, MD    39-038-250-2614 Less <<
NCT00439738 - Completed - -
NCT00150384 Hypertension ... More >>Dyslipidemia Less << Phase 4 Completed - -
NCT03657472 Hypertension ... More >>Hyperlipidemia Less << Phase 1 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT02294539 Hypertension Phase 4 Completed - Korea, Republic of ... More >> Kyung Hee University Hospital at Gangdong Seoul, Korea, Republic of Less <<
NCT01375322 Hypertension ... More >>Diabetes Mellitus, Type 2 Albuminuria Less << Phase 4 Completed - Taiwan ... More >> Chang Gung Memorial Hospital-Kaohsiung Kaohsiung, Taiwan, 833 Taichung Veterans General Hospital Taichung, Taiwan, 407 Tri-Service General Hospital Taipei, Taiwan, 114 Far Eastern Memorial Hospital Taipei, Taiwan, 220 Less <<
NCT02644395 Hypertension ... More >>Kidney Transplantation Less << Phase 3 Completed - Netherlands ... More >> ErasmusMC Rotterdam, Netherlands Less <<
NCT00791258 Hypertension Phase 4 Completed - -
NCT02373163 Blood Pressure, High Phase 4 Unknown June 2016 Peru ... More >> Centro de Investigacion PREVENCION Recruiting Arequipa, AQP, Peru Contact: Josefina E Medina-Lezama, MD    +5154251269    Josefina Medina Less <<
NCT01652339 Healthy Male Subjects Phase 1 Completed - Korea, Republic of ... More >> Inje University Busan Paik Hospital Busan, Korea, Republic of, 614-735 Less <<
NCT02996916 Efficacy of Olmesartan on Cere... More >>bral Glucose Metabolism in Essential Hypertension Less << Phase 4 Recruiting December 2020 Japan ... More >> Kurume University Hospital Recruiting Kurume, Japan, 830-0011 Contact: Nobuhiro Tahara, MD, PhD    +81-942-31-7580    ntahara@med.kurume-u.ac.jp    Contact: Akihiro Honda, MD, PhD    +81-942-31-7580    honda_akihiro@med.kurume-u.ac.jp Less <<
NCT01354613 Heart Failure With Preserved E... More >>jection Fraction Pulmonary Disease Left Ventricular Hypertrophy/Hypertension Less << Not Applicable Completed - United States, Wisconsin ... More >> UW - Madison Madison, Wisconsin, United States, 53705 Less <<
NCT01896661 Hypertension ... More >>Obstructive Sleep Apnea Less << Phase 3 Completed - Brazil ... More >> Hospital de Clinicas de Porto Alegre Porto Alegre, RS, Brazil, 90035-903 Less <<
NCT00360178 Hypertension Phase 3 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT01030458 - Completed - -
NCT01030458 Blood Pressure Phase 4 Completed - Cameroon ... More >> Ecole de Médecine de Douala Douala, Cameroon Hôpital Général de Yaoundé Yaoundé, Cameroon, BP 5408 Côte D'Ivoire Institut de Cardiologie d'Abidjan Abidjan, Côte D'Ivoire, BP V 206 Gabon Hôpital Central Universitaire de Libreville Libreville, Gabon, BP 4908 Nigeria University of Enugu Enugu, Nigeria University of Ilorin Ilorin, Nigeria, PMB 1515 Senegal Hôpital Aristide Le Dantec Dakar, Senegal Less <<
NCT00791258 - Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.76mL

0.35mL

0.18mL

8.82mL

1.76mL

0.88mL

17.64mL

3.53mL

1.76mL

References

 

Historical Records

Categories